 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0008753	NADPH dehydrogenase (quinone) activity	1	3.037371e-4	1.000000e+0	1.000000e+0	3.292321e+3	3.037371e-4	1	3.037371e-4	1.000000e+0	1	2.217111e-4	8.176705e-1	8.176705e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	CBR4
GO Molecular Function	GO:0003955	NAD(P)H dehydrogenase (quinone) activity	2	3.354533e-4	1.000000e+0	6.185759e-1	2.981041e+3	3.354533e-4	1	3.354533e-4	1.000000e+0	1	2.217111e-4	8.176705e-1	8.176705e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	CBR4
GO Molecular Function	GO:0051371	muscle alpha-actinin binding	3	6.390244e-4	1.000000e+0	7.855740e-1	1.564885e+3	6.390244e-4	1	6.390244e-4	1.000000e+0	3	8.866967e-4	1.000000e+0	1.000000e+0	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	PALLD
GO Molecular Function	GO:0070402	NADPH binding	4	1.047692e-3	1.000000e+0	9.659720e-1	9.544792e+2	1.047692e-3	1	1.047692e-3	1.000000e+0	4	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	CBR4
GO Molecular Function	GO:0048038	quinone binding	5	1.241040e-3	1.000000e+0	9.153911e-1	8.057755e+2	1.241040e-3	1	1.241040e-3	1.000000e+0	5	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	CBR4
GO Molecular Function	GO:0016655	oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor	6	2.856371e-3	1.000000e+0	1.000000e+0	3.500946e+2	2.856371e-3	1	2.856371e-3	1.000000e+0	9	6.751129e-3	1.000000e+0	1.000000e+0	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	CBR4
GO Molecular Function	GO:0051393	alpha-actinin binding	7	3.589268e-3	1.000000e+0	1.000000e+0	2.786083e+2	3.589268e-3	1	3.589268e-3	1.000000e+0	6	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	PALLD
GO Molecular Function	GO:0042805	actinin binding	8	4.029558e-3	1.000000e+0	1.000000e+0	2.481662e+2	4.029558e-3	1	4.029558e-3	1.000000e+0	7	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	PALLD
GO Molecular Function	GO:0050661	NADP binding	9	4.767337e-3	1.000000e+0	1.000000e+0	2.097607e+2	4.767337e-3	1	4.767337e-3	1.000000e+0	8	5.203711e-3	1.000000e+0	1.000000e+0	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	CBR4
GO Molecular Function	GO:0016651	oxidoreductase activity, acting on NAD(P)H	10	5.719761e-3	1.000000e+0	1.000000e+0	1.748325e+2	5.719761e-3	1	5.719761e-3	1.000000e+0	10	1.116569e-2	1.000000e+0	1.000000e+0	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	CBR4
GO Molecular Function	GO:0050662	coenzyme binding	11	1.487541e-2	1.000000e+0	1.000000e+0	6.722505e+1	1.487541e-2	1	1.487541e-2	1.000000e+0	11	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	CBR4
GO Molecular Function	GO:0048037	cofactor binding	12	2.190396e-2	1.000000e+0	1.000000e+0	4.565384e+1	2.190396e-2	1	2.190396e-2	1.000000e+0	12	2.839779e-2	1.000000e+0	1.000000e+0	3.496318e+1	2.860152e-2	1	258	5.000000e-1	3.875969e-3	unnamed	CBR4
GO Molecular Function	GO:0003779	actin binding	13	3.870965e-2	1.000000e+0	1.000000e+0	2.583335e+1	3.870965e-2	1	3.870965e-2	1.000000e+0	13	3.983792e-2	1.000000e+0	1.000000e+0	2.484986e+1	4.024167e-2	1	363	5.000000e-1	2.754821e-3	unnamed	PALLD
GO Molecular Function	GO:0016491	oxidoreductase activity	14	6.045513e-2	1.000000e+0	1.000000e+0	1.654119e+1	6.045513e-2	1	6.045513e-2	1.000000e+0	15	7.769532e-2	1.000000e+0	1.000000e+0	1.261608e+1	7.926390e-2	1	715	5.000000e-1	1.398601e-3	unnamed	CBR4
GO Molecular Function	GO:0008092	cytoskeletal protein binding	15	7.119601e-2	1.000000e+0	1.000000e+0	1.404573e+1	7.119601e-2	1	7.119601e-2	1.000000e+0	14	7.513832e-2	1.000000e+0	1.000000e+0	1.305427e+1	7.660329e-2	1	691	5.000000e-1	1.447178e-3	unnamed	PALLD
GO Molecular Function	GO:0000166	nucleotide binding	16	2.080686e-1	1.000000e+0	1.000000e+0	4.806107e+0	2.080686e-1	1	2.080686e-1	1.000000e+0	17	2.401781e-1	1.000000e+0	1.000000e+0	3.896544e+0	2.566377e-1	1	2315	5.000000e-1	4.319654e-4	unnamed	CBR4
GO Molecular Function	GO:1901265	nucleoside phosphate binding	17	2.081652e-1	1.000000e+0	1.000000e+0	4.803877e+0	2.081652e-1	1	2.081652e-1	1.000000e+0	18	2.402748e-1	1.000000e+0	1.000000e+0	3.894862e+0	2.567485e-1	1	2316	5.000000e-1	4.317789e-4	unnamed	CBR4
GO Molecular Function	GO:0036094	small molecule binding	18	2.286651e-1	1.000000e+0	1.000000e+0	4.373209e+0	2.286651e-1	1	2.286651e-1	1.000000e+0	19	2.643352e-1	1.000000e+0	1.000000e+0	3.514024e+0	2.845740e-1	1	2567	5.000000e-1	3.895598e-4	unnamed	CBR4
GO Molecular Function	GO:0043168	anion binding	19	2.579088e-1	1.000000e+0	1.000000e+0	3.877340e+0	2.579088e-1	1	2.579088e-1	1.000000e+0	20	2.792822e-1	1.000000e+0	1.000000e+0	3.310275e+0	3.020897e-1	1	2725	5.000000e-1	3.669725e-4	unnamed	CBR4
GO Molecular Function	GO:1901363	heterocyclic compound binding	20	4.273925e-1	1.000000e+0	1.000000e+0	2.339769e+0	4.273925e-1	1	4.273925e-1	1.000000e+0	22	5.012582e-1	1.000000e+0	1.000000e+0	1.701981e+0	5.875506e-1	1	5300	5.000000e-1	1.886792e-4	unnamed	CBR4
GO Molecular Function	GO:0097159	organic cyclic compound binding	21	4.323803e-1	1.000000e+0	1.000000e+0	2.312779e+0	4.323803e-1	1	4.323803e-1	1.000000e+0	23	5.069571e-1	1.000000e+0	1.000000e+0	1.678857e+0	5.956433e-1	1	5373	5.000000e-1	1.861158e-4	unnamed	CBR4
GO Molecular Function	GO:0003824	catalytic activity	22	4.361959e-1	1.000000e+0	1.000000e+0	2.292548e+0	4.361959e-1	1	4.361959e-1	1.000000e+0	24	5.163312e-1	1.000000e+0	1.000000e+0	1.641882e+0	6.090571e-1	1	5494	5.000000e-1	1.820167e-4	unnamed	CBR4
GO Molecular Function	GO:0043167	ion binding	23	5.095070e-1	1.000000e+0	1.000000e+0	1.962682e+0	5.095070e-1	1	5.095070e-1	1.000000e+0	25	5.570694e-1	1.000000e+0	1.000000e+0	1.494945e+0	6.689208e-1	1	6034	5.000000e-1	1.657275e-4	unnamed	CBR4
GO Molecular Function	GO:0005515	protein binding	24	6.181781e-1	1.000000e+0	1.000000e+0	1.617657e+0	6.181781e-1	1	6.181781e-1	1.000000e+0	16	1.964729e-1	1.000000e+0	1.000000e+0	2.255971e+0	8.865362e-1	2	7997	1.000000e+0	2.500938e-4	unnamed	CBR4,PALLD
GO Molecular Function	GO:0005488	binding	25	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	21	4.553379e-1	1.000000e+0	1.000000e+0	1.481929e+0	1.349593e+0	2	12174	1.000000e+0	1.642845e-4	unnamed	CBR4,PALLD
GO Biological Process	GO:0044597	daunorubicin metabolic process	1	5.394336e-4	1.000000e+0	1.000000e+0	1.853796e+3	5.394336e-4	1	5.394336e-4	1.000000e+0	1	8.866967e-4	1.000000e+0	1.000000e+0	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	CBR4
GO Biological Process	GO:0044598	doxorubicin metabolic process	1	5.394336e-4	1.000000e+0	1.000000e+0	1.853796e+3	5.394336e-4	1	5.394336e-4	1.000000e+0	1	8.866967e-4	1.000000e+0	1.000000e+0	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	CBR4
GO Biological Process	GO:0030638	polyketide metabolic process	3	6.558263e-4	1.000000e+0	1.000000e+0	1.524794e+3	6.558263e-4	1	6.558263e-4	1.000000e+0	3	9.975062e-4	1.000000e+0	1.000000e+0	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	CBR4
GO Biological Process	GO:0016137	glycoside metabolic process	4	6.941718e-4	1.000000e+0	1.000000e+0	1.440566e+3	6.941718e-4	1	6.941718e-4	1.000000e+0	4	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	CBR4
GO Biological Process	GO:1901661	quinone metabolic process	5	1.642802e-3	1.000000e+0	1.000000e+0	6.087160e+2	1.642802e-3	1	1.642802e-3	1.000000e+0	5	2.880326e-3	1.000000e+0	1.000000e+0	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	CBR4
GO Biological Process	GO:0019748	secondary metabolic process	6	3.742738e-3	1.000000e+0	1.000000e+0	2.671841e+2	3.742738e-3	1	3.742738e-3	1.000000e+0	6	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	CBR4
GO Biological Process	GO:0042180	cellular ketone metabolic process	7	3.770613e-3	1.000000e+0	1.000000e+0	2.652089e+2	3.770613e-3	1	3.770613e-3	1.000000e+0	8	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	CBR4
GO Biological Process	GO:0051289	protein homotetramerization	8	4.150438e-3	1.000000e+0	1.000000e+0	2.409385e+2	4.150438e-3	1	4.150438e-3	1.000000e+0	7	5.756499e-3	1.000000e+0	1.000000e+0	1.734712e+2	5.764647e-3	1	52	5.000000e-1	1.923077e-2	unnamed	CBR4
GO Biological Process	GO:0051262	protein tetramerization	9	7.273899e-3	1.000000e+0	1.000000e+0	1.374779e+2	7.273899e-3	1	7.273899e-3	1.000000e+0	9	9.069997e-3	1.000000e+0	1.000000e+0	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	CBR4
GO Biological Process	GO:0006633	fatty acid biosynthetic process	10	9.579437e-3	1.000000e+0	1.000000e+0	1.043903e+2	9.579437e-3	1	9.579437e-3	1.000000e+0	10	1.237796e-2	1.000000e+0	1.000000e+0	8.054018e+1	1.241616e-2	1	112	5.000000e-1	8.928571e-3	unnamed	CBR4
GO Biological Process	GO:0072330	monocarboxylic acid biosynthetic process	11	1.463305e-2	1.000000e+0	1.000000e+0	6.833847e+1	1.463305e-2	1	1.463305e-2	1.000000e+0	11	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	CBR4
GO Biological Process	GO:0051260	protein homooligomerization	12	1.990616e-2	1.000000e+0	1.000000e+0	5.023570e+1	1.990616e-2	1	1.990616e-2	1.000000e+0	12	2.380277e-2	1.000000e+0	1.000000e+0	4.176157e+1	2.394546e-2	1	216	5.000000e-1	4.629630e-3	unnamed	CBR4
GO Biological Process	GO:0051186	cofactor metabolic process	13	2.040573e-2	1.000000e+0	1.000000e+0	4.900585e+1	2.040573e-2	1	2.040573e-2	1.000000e+0	13	2.697668e-2	1.000000e+0	1.000000e+0	3.681837e+1	2.716036e-2	1	245	5.000000e-1	4.081633e-3	unnamed	CBR4
GO Biological Process	GO:0006631	fatty acid metabolic process	14	2.242543e-2	1.000000e+0	1.000000e+0	4.459223e+1	2.242543e-2	1	2.242543e-2	1.000000e+0	14	2.959946e-2	1.000000e+0	1.000000e+0	3.353346e+1	2.982096e-2	1	269	5.000000e-1	3.717472e-3	unnamed	CBR4
GO Biological Process	GO:0046394	carboxylic acid biosynthetic process	15	2.519210e-2	1.000000e+0	1.000000e+0	3.969498e+1	2.519210e-2	1	2.519210e-2	1.000000e+0	15	3.003624e-2	1.000000e+0	1.000000e+0	3.304212e+1	3.026440e-2	1	273	5.000000e-1	3.663004e-3	unnamed	CBR4
GO Biological Process	GO:0051259	protein oligomerization	16	3.053708e-2	1.000000e+0	1.000000e+0	3.274707e+1	3.053708e-2	1	3.053708e-2	1.000000e+0	16	3.690264e-2	1.000000e+0	1.000000e+0	2.684673e+1	3.724849e-2	1	336	5.000000e-1	2.976190e-3	unnamed	CBR4
GO Biological Process	GO:0044283	small molecule biosynthetic process	17	3.466661e-2	1.000000e+0	1.000000e+0	2.884620e+1	3.466661e-2	1	3.466661e-2	1.000000e+0	17	4.309408e-2	1.000000e+0	1.000000e+0	2.295293e+1	4.356743e-2	1	393	5.000000e-1	2.544529e-3	unnamed	CBR4
GO Biological Process	GO:0032787	monocarboxylic acid metabolic process	18	3.578238e-2	1.000000e+0	1.000000e+0	2.794672e+1	3.578238e-2	1	3.578238e-2	1.000000e+0	19	4.558673e-2	1.000000e+0	1.000000e+0	2.168389e+1	4.611718e-2	1	416	5.000000e-1	2.403846e-3	unnamed	CBR4
GO Biological Process	GO:0044711	single-organism biosynthetic process	19	3.645402e-2	1.000000e+0	1.000000e+0	2.743181e+1	3.645402e-2	1	3.645402e-2	1.000000e+0	18	4.439500e-2	1.000000e+0	1.000000e+0	2.227284e+1	4.489773e-2	1	405	5.000000e-1	2.469136e-3	unnamed	CBR4
GO Biological Process	GO:1901657	glycosyl compound metabolic process	20	4.374541e-2	1.000000e+0	1.000000e+0	2.285954e+1	4.374541e-2	1	4.374541e-2	1.000000e+0	23	6.208551e-2	1.000000e+0	1.000000e+0	1.585325e+1	6.307854e-2	1	569	5.000000e-1	1.757469e-3	unnamed	CBR4
GO Biological Process	GO:0008610	lipid biosynthetic process	21	4.482047e-2	1.000000e+0	1.000000e+0	2.231123e+1	4.482047e-2	1	4.482047e-2	1.000000e+0	22	5.390802e-2	1.000000e+0	1.000000e+0	1.829716e+1	5.465329e-2	1	493	5.000000e-1	2.028398e-3	unnamed	CBR4
GO Biological Process	GO:0019752	carboxylic acid metabolic process	22	6.544102e-2	1.000000e+0	1.000000e+0	1.528093e+1	6.544102e-2	1	6.544102e-2	1.000000e+0	25	8.735845e-2	1.000000e+0	1.000000e+0	1.119169e+1	8.935203e-2	1	806	5.000000e-1	1.240695e-3	unnamed	CBR4
GO Biological Process	GO:0007010	cytoskeleton organization	23	7.068309e-2	1.000000e+0	1.000000e+0	1.414766e+1	7.068309e-2	1	7.068309e-2	1.000000e+0	24	7.673686e-2	1.000000e+0	1.000000e+0	1.277691e+1	7.826617e-2	1	706	5.000000e-1	1.416431e-3	unnamed	PALLD
GO Biological Process	GO:0044255	cellular lipid metabolic process	24	7.113785e-2	1.000000e+0	1.000000e+0	1.405721e+1	7.113785e-2	1	7.113785e-2	1.000000e+0	26	8.894639e-2	1.000000e+0	1.000000e+0	1.098721e+1	9.101491e-2	1	821	5.000000e-1	1.218027e-3	unnamed	CBR4
GO Biological Process	GO:0006461	protein complex assembly	25	7.319458e-2	1.000000e+0	1.000000e+0	1.366221e+1	7.319458e-2	1	7.319458e-2	1.000000e+0	27	9.201248e-2	1.000000e+0	1.000000e+0	1.061235e+1	9.422981e-2	1	850	5.000000e-1	1.176471e-3	unnamed	CBR4
GO Biological Process	GO:0070271	protein complex biogenesis	26	7.334148e-2	1.000000e+0	1.000000e+0	1.363485e+1	7.334148e-2	1	7.334148e-2	1.000000e+0	28	9.232937e-2	1.000000e+0	1.000000e+0	1.057503e+1	9.456239e-2	1	853	5.000000e-1	1.172333e-3	unnamed	CBR4
GO Biological Process	GO:0055114	oxidation-reduction process	27	7.921377e-2	1.000000e+0	1.000000e+0	1.262407e+1	7.921377e-2	1	7.921377e-2	1.000000e+0	30	9.970771e-2	1.000000e+0	1.000000e+0	9.773023e+0	1.023225e-1	1	923	5.000000e-1	1.083424e-3	unnamed	CBR4
GO Biological Process	GO:0043436	oxoacid metabolic process	28	8.179018e-2	1.000000e+0	1.000000e+0	1.222641e+1	8.179018e-2	1	8.179018e-2	1.000000e+0	29	9.918168e-2	1.000000e+0	1.000000e+0	9.826253e+0	1.017682e-1	1	918	5.000000e-1	1.089325e-3	unnamed	CBR4
GO Biological Process	GO:0006082	organic acid metabolic process	29	8.296012e-2	1.000000e+0	1.000000e+0	1.205398e+1	8.296012e-2	1	8.296012e-2	1.000000e+0	31	1.008644e-1	1.000000e+0	1.000000e+0	9.657923e+0	1.035419e-1	1	934	5.000000e-1	1.070664e-3	unnamed	CBR4
GO Biological Process	GO:0065003	macromolecular complex assembly	30	8.650677e-2	1.000000e+0	1.000000e+0	1.155979e+1	8.650677e-2	1	8.650677e-2	1.000000e+0	32	1.078938e-1	1.000000e+0	1.000000e+0	9.011489e+0	1.109695e-1	1	1001	5.000000e-1	9.990010e-4	unnamed	CBR4
GO Biological Process	GO:0006629	lipid metabolic process	31	9.193917e-2	1.000000e+0	1.000000e+0	1.087676e+1	9.193917e-2	1	9.193917e-2	1.000000e+0	33	1.144784e-1	1.000000e+0	1.000000e+0	8.477914e+0	1.179536e-1	1	1064	5.000000e-1	9.398496e-4	unnamed	CBR4
GO Biological Process	GO:0071822	protein complex subunit organization	32	9.514648e-2	1.000000e+0	1.000000e+0	1.051011e+1	9.514648e-2	1	9.514648e-2	1.000000e+0	34	1.196868e-1	1.000000e+0	1.000000e+0	8.097397e+0	1.234965e-1	1	1114	5.000000e-1	8.976661e-4	unnamed	CBR4
GO Biological Process	GO:0043933	macromolecular complex subunit organization	33	1.093852e-1	1.000000e+0	1.000000e+0	9.142007e+0	1.093852e-1	1	1.093852e-1	1.000000e+0	36	1.367658e-1	1.000000e+0	1.000000e+0	7.052776e+0	1.417881e-1	1	1279	5.000000e-1	7.818608e-4	unnamed	CBR4
GO Biological Process	GO:1901135	carbohydrate derivative metabolic process	34	1.134958e-1	1.000000e+0	1.000000e+0	8.810897e+0	1.134958e-1	1	1.134958e-1	1.000000e+0	35	1.288165e-1	1.000000e+0	1.000000e+0	7.504576e+0	1.332520e-1	1	1202	5.000000e-1	8.319468e-4	unnamed	CBR4
GO Biological Process	GO:0022607	cellular component assembly	35	1.412864e-1	1.000000e+0	1.000000e+0	7.077823e+0	1.412864e-1	1	1.412864e-1	1.000000e+0	37	1.584642e-1	1.000000e+0	1.000000e+0	6.049966e+0	1.652902e-1	1	1491	5.000000e-1	6.706908e-4	unnamed	CBR4
GO Biological Process	GO:0044085	cellular component biogenesis	36	1.485548e-1	1.000000e+0	1.000000e+0	6.731524e+0	1.485548e-1	1	1.485548e-1	1.000000e+0	38	1.727427e-1	1.000000e+0	1.000000e+0	5.527267e+0	1.809212e-1	1	1632	5.000000e-1	6.127451e-4	unnamed	CBR4
GO Biological Process	GO:0006996	organelle organization	37	1.979117e-1	1.000000e+0	1.000000e+0	5.052758e+0	1.979117e-1	1	1.979117e-1	1.000000e+0	39	2.321362e-1	1.000000e+0	1.000000e+0	4.041443e+0	2.474364e-1	1	2232	5.000000e-1	4.480287e-4	unnamed	PALLD
GO Biological Process	GO:0044281	small molecule metabolic process	38	2.001784e-1	1.000000e+0	1.000000e+0	4.995545e+0	2.001784e-1	1	2.001784e-1	1.000000e+0	40	2.509628e-1	1.000000e+0	1.000000e+0	3.716728e+0	2.690538e-1	1	2427	5.000000e-1	4.120313e-4	unnamed	CBR4
GO Biological Process	GO:0044710	single-organism metabolic process	39	2.517961e-1	1.000000e+0	1.000000e+0	3.971468e+0	2.517961e-1	1	2.517961e-1	1.000000e+0	41	3.105584e-1	1.000000e+0	1.000000e+0	2.946913e+0	3.393382e-1	1	3061	5.000000e-1	3.266906e-4	unnamed	CBR4
GO Biological Process	GO:0044249	cellular biosynthetic process	40	3.470471e-1	1.000000e+0	1.000000e+0	2.881453e+0	3.470471e-1	1	3.470471e-1	1.000000e+0	42	4.041671e-1	1.000000e+0	1.000000e+0	2.192102e+0	4.561831e-1	1	4115	5.000000e-1	2.430134e-4	unnamed	CBR4
GO Biological Process	GO:1901576	organic substance biosynthetic process	41	3.536536e-1	1.000000e+0	1.000000e+0	2.827626e+0	3.536536e-1	1	3.536536e-1	1.000000e+0	43	4.118439e-1	1.000000e+0	1.000000e+0	2.145184e+0	4.661604e-1	1	4205	5.000000e-1	2.378121e-4	unnamed	CBR4
GO Biological Process	GO:0009058	biosynthetic process	42	3.586722e-1	1.000000e+0	1.000000e+0	2.788061e+0	3.586722e-1	1	3.586722e-1	1.000000e+0	44	4.178650e-1	1.000000e+0	1.000000e+0	2.109565e+0	4.740314e-1	1	4276	5.000000e-1	2.338634e-4	unnamed	CBR4
GO Biological Process	GO:0016043	cellular component organization	43	3.831577e-1	1.000000e+0	1.000000e+0	2.609891e+0	3.831577e-1	1	3.831577e-1	1.000000e+0	20	4.979004e-2	1.000000e+0	1.000000e+0	4.481123e+0	4.463167e-1	2	4026	1.000000e+0	4.967710e-4	unnamed	CBR4,PALLD
GO Biological Process	GO:0071840	cellular component organization or biogenesis	44	3.897194e-1	1.000000e+0	1.000000e+0	2.565949e+0	3.897194e-1	1	3.897194e-1	1.000000e+0	21	5.287922e-2	1.000000e+0	1.000000e+0	4.348277e+0	4.599523e-1	2	4149	1.000000e+0	4.820439e-4	unnamed	CBR4,PALLD
GO Biological Process	GO:0006807	nitrogen compound metabolic process	45	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	45	4.994558e-1	1.000000e+0	1.000000e+0	1.709399e+0	5.850008e-1	1	5277	5.000000e-1	1.895016e-4	unnamed	CBR4
GO Biological Process	GO:0044237	cellular metabolic process	46	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	47	7.045181e-1	1.000000e+0	1.000000e+0	1.095519e+0	9.128097e-1	1	8234	5.000000e-1	1.214477e-4	unnamed	CBR4
GO Biological Process	GO:0044238	primary metabolic process	47	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	48	7.093792e-1	1.000000e+0	1.000000e+0	1.084847e+0	9.217893e-1	1	8315	5.000000e-1	1.202646e-4	unnamed	CBR4
GO Biological Process	GO:0071704	organic substance metabolic process	48	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	49	7.239536e-1	1.000000e+0	1.000000e+0	1.053551e+0	9.491713e-1	1	8562	5.000000e-1	1.167951e-4	unnamed	CBR4
GO Biological Process	GO:0008152	metabolic process	49	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	50	7.596471e-1	1.000000e+0	1.000000e+0	9.809156e-1	1.019456e+0	1	9196	5.000000e-1	1.087429e-4	unnamed	CBR4
GO Biological Process	GO:0044763	single-organism cellular process	50	7.497126e-1	1.000000e+0	1.000000e+0	1.333844e+0	7.497126e-1	1	7.497126e-1	1.000000e+0	51	8.068544e-1	1.000000e+0	1.000000e+0	8.920589e-1	1.121002e+0	1	10112	5.000000e-1	9.889241e-5	unnamed	PALLD
GO Biological Process	GO:0044699	single-organism process	51	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	52	8.529291e-1	1.000000e+0	1.000000e+0	8.110502e-1	1.232969e+0	1	11122	5.000000e-1	8.991189e-5	unnamed	PALLD
GO Biological Process	GO:0009987	cellular process	52	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	46	5.606826e-1	1.000000e+0	1.000000e+0	1.335480e+0	1.497589e+0	2	13509	1.000000e+0	1.480494e-4	unnamed	CBR4,PALLD
GO Cellular Component	GO:0005884	actin filament	1	6.436030e-3	1.000000e+0	1.000000e+0	1.553753e+2	6.436030e-3	1	6.436030e-3	1.000000e+0	1	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	PALLD
GO Cellular Component	GO:0005925	focal adhesion	2	1.246052e-2	1.000000e+0	1.000000e+0	8.025350e+1	1.246052e-2	1	1.246052e-2	1.000000e+0	4	1.447015e-2	1.000000e+0	1.000000e+0	6.885878e+1	1.452248e-2	1	131	5.000000e-1	7.633588e-3	unnamed	PALLD
GO Cellular Component	GO:0005924	cell-substrate adherens junction	3	1.273928e-2	1.000000e+0	1.000000e+0	7.849738e+1	1.273928e-2	1	1.273928e-2	1.000000e+0	5	1.491033e-2	1.000000e+0	1.000000e+0	6.681852e+1	1.496591e-2	1	135	5.000000e-1	7.407407e-3	unnamed	PALLD
GO Cellular Component	GO:0030018	Z disc	4	1.367842e-2	1.000000e+0	1.000000e+0	7.310788e+1	1.367842e-2	1	1.367842e-2	1.000000e+0	2	1.083493e-2	1.000000e+0	1.000000e+0	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	PALLD
GO Cellular Component	GO:0031674	I band	5	1.446111e-2	1.000000e+0	1.000000e+0	6.915100e+1	1.446111e-2	1	1.446111e-2	1.000000e+0	3	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	PALLD
GO Cellular Component	GO:0001726	ruffle	6	1.447794e-2	1.000000e+0	1.000000e+0	6.907058e+1	1.447794e-2	1	1.447794e-2	1.000000e+0	6	1.513038e-2	1.000000e+0	1.000000e+0	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	PALLD
GO Cellular Component	GO:0030055	cell-substrate junction	7	1.449286e-2	1.000000e+0	1.000000e+0	6.899951e+1	1.449286e-2	1	1.449286e-2	1.000000e+0	8	1.568040e-2	1.000000e+0	1.000000e+0	6.352465e+1	1.574192e-2	1	142	5.000000e-1	7.042254e-3	unnamed	PALLD
GO Cellular Component	GO:0030027	lamellipodium	8	1.646314e-2	1.000000e+0	1.000000e+0	6.074177e+1	1.646314e-2	1	1.646314e-2	1.000000e+0	6	1.513038e-2	1.000000e+0	1.000000e+0	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	PALLD
GO Cellular Component	GO:0030017	sarcomere	9	1.887048e-2	1.000000e+0	1.000000e+0	5.299283e+1	1.887048e-2	1	1.887048e-2	1.000000e+0	9	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	PALLD
GO Cellular Component	GO:0044449	contractile fiber part	10	2.023967e-2	1.000000e+0	1.000000e+0	4.940792e+1	2.023967e-2	1	2.023967e-2	1.000000e+0	10	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	PALLD
GO Cellular Component	GO:0030016	myofibril	11	2.078730e-2	1.000000e+0	1.000000e+0	4.810630e+1	2.078730e-2	1	2.078730e-2	1.000000e+0	11	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	PALLD
GO Cellular Component	GO:0005759	mitochondrial matrix	12	2.150026e-2	1.000000e+0	1.000000e+0	4.651106e+1	2.150026e-2	1	2.150026e-2	1.000000e+0	16	3.374495e-2	1.000000e+0	1.000000e+0	2.938274e+1	3.403359e-2	1	307	5.000000e-1	3.257329e-3	unnamed	CBR4
GO Cellular Component	GO:0043292	contractile fiber	13	2.185705e-2	1.000000e+0	1.000000e+0	4.575183e+1	2.185705e-2	1	2.185705e-2	1.000000e+0	12	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	PALLD
GO Cellular Component	GO:0005912	adherens junction	14	2.413175e-2	1.000000e+0	1.000000e+0	4.143918e+1	2.413175e-2	1	2.413175e-2	1.000000e+0	13	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	PALLD
GO Cellular Component	GO:0070161	anchoring junction	15	2.592477e-2	1.000000e+0	1.000000e+0	3.857314e+1	2.592477e-2	1	2.592477e-2	1.000000e+0	14	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	PALLD
GO Cellular Component	GO:0031252	cell leading edge	16	3.421756e-2	1.000000e+0	1.000000e+0	2.922476e+1	3.421756e-2	1	3.421756e-2	1.000000e+0	15	3.167331e-2	1.000000e+0	1.000000e+0	3.132118e+1	3.192728e-2	1	288	5.000000e-1	3.472222e-3	unnamed	PALLD
GO Cellular Component	GO:0015629	actin cytoskeleton	17	3.742279e-2	1.000000e+0	1.000000e+0	2.672168e+1	3.742279e-2	1	3.742279e-2	1.000000e+0	17	4.385306e-2	1.000000e+0	1.000000e+0	2.255125e+1	4.434344e-2	1	400	5.000000e-1	2.500000e-3	unnamed	PALLD
GO Cellular Component	GO:0044429	mitochondrial part	18	5.499540e-2	1.000000e+0	1.000000e+0	1.818334e+1	5.499540e-2	1	5.499540e-2	1.000000e+0	19	8.598112e-2	1.000000e+0	1.000000e+0	1.137516e+1	8.791087e-2	1	793	5.000000e-1	1.261034e-3	unnamed	CBR4
GO Cellular Component	GO:0030054	cell junction	19	1.083533e-1	1.000000e+0	1.000000e+0	9.229066e+0	1.083533e-1	1	1.083533e-1	1.000000e+0	18	8.587513e-2	1.000000e+0	1.000000e+0	1.138952e+1	8.780001e-2	1	792	5.000000e-1	1.262626e-3	unnamed	PALLD
GO Cellular Component	GO:0005739	mitochondrion	20	1.171632e-1	1.000000e+0	1.000000e+0	8.535104e+0	1.171632e-1	1	1.171632e-1	1.000000e+0	25	1.680979e-1	1.000000e+0	1.000000e+0	5.687579e+0	1.758217e-1	1	1586	5.000000e-1	6.305170e-4	unnamed	CBR4
GO Cellular Component	GO:0044430	cytoskeletal part	21	1.208518e-1	1.000000e+0	1.000000e+0	8.274597e+0	1.208518e-1	1	1.208518e-1	1.000000e+0	23	1.458062e-1	1.000000e+0	1.000000e+0	6.598756e+0	1.515437e-1	1	1367	5.000000e-1	7.315289e-4	unnamed	PALLD
GO Cellular Component	GO:0042995	cell projection	22	1.598517e-1	1.000000e+0	1.000000e+0	6.255796e+0	1.598517e-1	1	1.598517e-1	1.000000e+0	22	1.387218e-1	1.000000e+0	1.000000e+0	6.949538e+0	1.438945e-1	1	1298	5.000000e-1	7.704160e-4	unnamed	PALLD
GO Cellular Component	GO:0005856	cytoskeleton	23	1.730861e-1	1.000000e+0	1.000000e+0	5.777472e+0	1.730861e-1	1	1.730861e-1	1.000000e+0	26	1.976595e-1	1.000000e+0	1.000000e+0	4.795587e+0	2.085250e-1	1	1881	5.000000e-1	5.316321e-4	unnamed	PALLD
GO Cellular Component	GO:0070013	intracellular organelle lumen	24	2.178720e-1	1.000000e+0	1.000000e+0	4.589852e+0	2.178720e-1	1	2.178720e-1	1.000000e+0	28	2.759844e-1	1.000000e+0	1.000000e+0	3.353346e+0	2.982096e-1	1	2690	5.000000e-1	3.717472e-4	unnamed	CBR4
GO Cellular Component	GO:0043233	organelle lumen	25	2.231770e-1	1.000000e+0	1.000000e+0	4.480748e+0	2.231770e-1	1	2.231770e-1	1.000000e+0	29	2.816332e-1	1.000000e+0	1.000000e+0	3.280182e+0	3.048611e-1	1	2750	5.000000e-1	3.636364e-4	unnamed	CBR4
GO Cellular Component	GO:0031974	membrane-enclosed lumen	26	2.255118e-1	1.000000e+0	1.000000e+0	4.434357e+0	2.255118e-1	1	2.255118e-1	1.000000e+0	30	2.863237e-1	1.000000e+0	1.000000e+0	3.221607e+0	3.104041e-1	1	2800	5.000000e-1	3.571429e-4	unnamed	CBR4
GO Cellular Component	GO:0043232	intracellular non-membrane-bounded organelle	27	2.709879e-1	1.000000e+0	1.000000e+0	3.690202e+0	2.709879e-1	1	2.709879e-1	1.000000e+0	33	3.348266e-1	1.000000e+0	1.000000e+0	2.711301e+0	3.688266e-1	1	3327	5.000000e-1	3.005711e-4	unnamed	PALLD
GO Cellular Component	GO:0043234	protein complex	28	3.027166e-1	1.000000e+0	1.000000e+0	3.303419e+0	3.027166e-1	1	3.027166e-1	1.000000e+0	34	3.630030e-1	1.000000e+0	1.000000e+0	2.476798e+0	4.037470e-1	1	3642	5.000000e-1	2.745744e-4	unnamed	PALLD
GO Cellular Component	GO:0032991	macromolecular complex	29	3.347910e-1	1.000000e+0	1.000000e+0	2.986938e+0	3.347910e-1	1	3.347910e-1	1.000000e+0	37	4.132884e-1	1.000000e+0	1.000000e+0	2.136547e+0	4.680450e-1	1	4222	5.000000e-1	2.368546e-4	unnamed	PALLD
GO Cellular Component	GO:0044446	intracellular organelle part	30	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	20	1.292379e-1	1.000000e+0	1.000000e+0	2.781529e+0	7.190289e-1	2	6486	1.000000e+0	3.083565e-4	unnamed	CBR4,PALLD
GO Cellular Component	GO:0005634	nucleus	31	4.766312e-1	1.000000e+0	1.000000e+0	2.098058e+0	4.766312e-1	1	4.766312e-1	1.000000e+0	40	5.600157e-1	1.000000e+0	1.000000e+0	1.485100e+0	6.733551e-1	1	6074	5.000000e-1	1.646362e-4	unnamed	PALLD
GO Cellular Component	GO:0044422	organelle part	32	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	21	1.337401e-1	1.000000e+0	1.000000e+0	2.734313e+0	7.314450e-1	2	6598	1.000000e+0	3.031222e-4	unnamed	CBR4,PALLD
GO Cellular Component	GO:0044444	cytoplasmic part	33	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	24	1.519576e-1	1.000000e+0	1.000000e+0	2.565193e+0	7.796685e-1	2	7033	1.000000e+0	2.843737e-4	unnamed	CBR4,PALLD
GO Cellular Component	GO:0005737	cytoplasm	34	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	27	2.746502e-1	1.000000e+0	1.000000e+0	1.908091e+0	1.048168e+0	2	9455	1.000000e+0	2.115283e-4	unnamed	CBR4,PALLD
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	35	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	31	3.079649e-1	1.000000e+0	1.000000e+0	1.801938e+0	1.109916e+0	2	10012	1.000000e+0	1.997603e-4	unnamed	CBR4,PALLD
GO Cellular Component	GO:0043227	membrane-bounded organelle	36	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	32	3.100602e-1	1.000000e+0	1.000000e+0	1.795839e+0	1.113685e+0	2	10046	1.000000e+0	1.990842e-4	unnamed	CBR4,PALLD
GO Cellular Component	GO:0043229	intracellular organelle	37	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	35	3.712075e-1	1.000000e+0	1.000000e+0	1.641285e+0	1.218558e+0	2	10992	1.000000e+0	1.819505e-4	unnamed	CBR4,PALLD
GO Cellular Component	GO:0043226	organelle	38	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	36	3.733721e-1	1.000000e+0	1.000000e+0	1.636520e+0	1.222105e+0	2	11024	1.000000e+0	1.814224e-4	unnamed	CBR4,PALLD
GO Cellular Component	GO:0044424	intracellular part	39	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	38	4.860618e-1	1.000000e+0	1.000000e+0	1.434330e+0	1.394379e+0	2	12578	1.000000e+0	1.590078e-4	unnamed	CBR4,PALLD
GO Cellular Component	GO:0005622	intracellular	40	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	39	4.992900e-1	1.000000e+0	1.000000e+0	1.415202e+0	1.413225e+0	2	12748	1.000000e+0	1.568874e-4	unnamed	CBR4,PALLD
GO Cellular Component	GO:0044464	cell part	41	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	41	6.728810e-1	1.000000e+0	1.000000e+0	1.219069e+0	1.640596e+0	2	14799	1.000000e+0	1.351443e-4	unnamed	CBR4,PALLD
GO Cellular Component	GO:0005623	cell	42	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	42	6.729719e-1	1.000000e+0	1.000000e+0	1.218986e+0	1.640707e+0	2	14800	1.000000e+0	1.351351e-4	unnamed	CBR4,PALLD
Mouse Phenotype	MP:0011708	decreased fibroblast cell migration	1	5.113023e-3	1.000000e+0	1.000000e+0	1.955790e+2	5.113023e-3	1	5.113023e-3	1.000000e+0	1	3.655089e-3	1.000000e+0	1.000000e+0	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	PALLD
Mouse Phenotype	MP:0011706	abnormal fibroblast migration	2	5.395841e-3	1.000000e+0	1.000000e+0	1.853279e+2	5.395841e-3	1	5.395841e-3	1.000000e+0	2	3.987038e-3	1.000000e+0	1.000000e+0	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	PALLD
Mouse Phenotype	MP:0003566	abnormal cell adhesion	3	6.829933e-3	1.000000e+0	1.000000e+0	1.464143e+2	6.829933e-3	1	6.829933e-3	1.000000e+0	3	6.751129e-3	1.000000e+0	1.000000e+0	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	PALLD
Mouse Phenotype	MP:0000914	exencephaly	4	2.974234e-2	1.000000e+0	1.000000e+0	3.362211e+1	2.974234e-2	1	2.974234e-2	1.000000e+0	5	2.632043e-2	1.000000e+0	1.000000e+0	3.774268e+1	2.649521e-2	1	239	5.000000e-1	4.184100e-3	unnamed	PALLD
Mouse Phenotype	MP:0000929	open neural tube	5	3.434163e-2	1.000000e+0	1.000000e+0	2.911918e+1	3.434163e-2	1	3.434163e-2	1.000000e+0	4	2.599222e-2	1.000000e+0	1.000000e+0	3.822246e+1	2.616263e-2	1	236	5.000000e-1	4.237288e-3	unnamed	PALLD
Mouse Phenotype	MP:0003720	abnormal neural tube closure	6	4.319769e-2	1.000000e+0	1.000000e+0	2.314939e+1	4.319769e-2	1	4.319769e-2	1.000000e+0	7	3.527000e-2	1.000000e+0	1.000000e+0	2.810125e+1	3.558561e-2	1	321	5.000000e-1	3.115265e-3	unnamed	PALLD
Mouse Phenotype	MP:0011099	complete lethality throughout fetal growth and development	7	4.475847e-2	1.000000e+0	1.000000e+0	2.234214e+1	4.475847e-2	1	4.475847e-2	1.000000e+0	6	3.232775e-2	1.000000e+0	1.000000e+0	3.068197e+1	3.259243e-2	1	294	5.000000e-1	3.401361e-3	unnamed	PALLD
Mouse Phenotype	MP:0003091	abnormal cell migration	8	6.074124e-2	1.000000e+0	1.000000e+0	1.646328e+1	6.074124e-2	1	6.074124e-2	1.000000e+0	9	5.056227e-2	1.000000e+0	1.000000e+0	1.952489e+1	5.121667e-2	1	462	5.000000e-1	2.164502e-3	unnamed	PALLD
Mouse Phenotype	MP:0002151	abnormal neural tube morphology/development	9	6.639156e-2	1.000000e+0	1.000000e+0	1.506215e+1	6.639156e-2	1	6.639156e-2	1.000000e+0	10	5.681724e-2	1.000000e+0	1.000000e+0	1.734712e+1	5.764647e-2	1	520	5.000000e-1	1.923077e-3	unnamed	PALLD
Mouse Phenotype	MP:0006208	lethality throughout fetal growth and development	10	6.727622e-2	1.000000e+0	1.000000e+0	1.486409e+1	6.727622e-2	1	6.727622e-2	1.000000e+0	8	5.023817e-2	1.000000e+0	1.000000e+0	1.965251e+1	5.088410e-2	1	459	5.000000e-1	2.178649e-3	unnamed	PALLD
Mouse Phenotype	MP:0000913	abnormal brain development	11	9.561960e-2	1.000000e+0	1.000000e+0	1.045811e+1	9.561960e-2	1	9.561960e-2	1.000000e+0	11	7.396518e-2	1.000000e+0	1.000000e+0	1.326544e+1	7.538385e-2	1	680	5.000000e-1	1.470588e-3	unnamed	PALLD
Mouse Phenotype	MP:0002085	abnormal embryonic tissue morphology	12	1.131386e-1	1.000000e+0	1.000000e+0	8.838720e+0	1.131386e-1	1	1.131386e-1	1.000000e+0	12	9.391298e-2	1.000000e+0	1.000000e+0	1.039228e+1	9.622526e-2	1	868	5.000000e-1	1.152074e-3	unnamed	PALLD
Mouse Phenotype	MP:0003861	abnormal nervous system development	13	1.509392e-1	1.000000e+0	1.000000e+0	6.625185e+0	1.509392e-1	1	1.509392e-1	1.000000e+0	13	1.151042e-1	1.000000e+0	1.000000e+0	8.430374e+0	1.186187e-1	1	1070	5.000000e-1	9.345794e-4	unnamed	PALLD
Mouse Phenotype	MP:0001672	abnormal embryogenesis/ development	14	1.759787e-1	1.000000e+0	1.000000e+0	5.682507e+0	1.759787e-1	1	1.759787e-1	1.000000e+0	15	1.649603e-1	1.000000e+0	1.000000e+0	5.800965e+0	1.723851e-1	1	1555	5.000000e-1	6.430868e-4	unnamed	PALLD
Mouse Phenotype	MP:0002152	abnormal brain morphology	15	1.867872e-1	1.000000e+0	1.000000e+0	5.353687e+0	1.867872e-1	1	1.867872e-1	1.000000e+0	14	1.513302e-1	1.000000e+0	1.000000e+0	6.347994e+0	1.575301e-1	1	1421	5.000000e-1	7.037298e-4	unnamed	PALLD
Mouse Phenotype	MP:0002080	prenatal lethality	16	2.134127e-1	1.000000e+0	1.000000e+0	4.685758e+0	2.134127e-1	1	2.134127e-1	1.000000e+0	16	2.134693e-1	1.000000e+0	1.000000e+0	4.419647e+0	2.262624e-1	1	2041	5.000000e-1	4.899559e-4	unnamed	PALLD
Mouse Phenotype	MP:0010832	lethality during fetal growth through weaning	17	2.758093e-1	1.000000e+0	1.000000e+0	3.625694e+0	2.758093e-1	1	2.758093e-1	1.000000e+0	17	2.188676e-1	1.000000e+0	1.000000e+0	4.303674e+0	2.323596e-1	1	2096	5.000000e-1	4.770992e-4	unnamed	PALLD
Mouse Phenotype	MP:0003632	abnormal nervous system morphology	18	2.827167e-1	1.000000e+0	1.000000e+0	3.537110e+0	2.827167e-1	1	2.827167e-1	1.000000e+0	18	2.350478e-1	1.000000e+0	1.000000e+0	3.987843e+0	2.507622e-1	1	2262	5.000000e-1	4.420866e-4	unnamed	PALLD
Mouse Phenotype	MP:0005621	abnormal cell physiology	19	3.078333e-1	1.000000e+0	1.000000e+0	3.248512e+0	3.078333e-1	1	3.078333e-1	1.000000e+0	20	3.046545e-1	1.000000e+0	1.000000e+0	3.009843e+0	3.322432e-1	1	2997	5.000000e-1	3.336670e-4	unnamed	PALLD
Mouse Phenotype	MP:0005384	cellular phenotype	20	3.121556e-1	1.000000e+0	1.000000e+0	3.203530e+0	3.121556e-1	1	3.121556e-1	1.000000e+0	21	3.123982e-1	1.000000e+0	1.000000e+0	2.927783e+0	3.415553e-1	1	3081	5.000000e-1	3.245699e-4	unnamed	PALLD
Mouse Phenotype	MP:0003631	nervous system phenotype	21	3.410385e-1	1.000000e+0	1.000000e+0	2.932220e+0	3.410385e-1	1	3.410385e-1	1.000000e+0	19	2.844493e-1	1.000000e+0	1.000000e+0	3.244784e+0	3.081869e-1	1	2780	5.000000e-1	3.597122e-4	unnamed	PALLD
Mouse Phenotype	MP:0010770	preweaning lethality	22	3.585301e-1	1.000000e+0	1.000000e+0	2.789166e+0	3.585301e-1	1	3.585301e-1	1.000000e+0	22	3.286641e-1	1.000000e+0	1.000000e+0	2.767874e+0	3.612882e-1	1	3259	5.000000e-1	3.068426e-4	unnamed	PALLD
Mouse Phenotype	MP:0010769	abnormal survival	23	3.982821e-1	1.000000e+0	1.000000e+0	2.510783e+0	3.982821e-1	1	3.982821e-1	1.000000e+0	23	3.748920e-1	1.000000e+0	1.000000e+0	2.388271e+0	4.187129e-1	1	3777	5.000000e-1	2.647604e-4	unnamed	PALLD
Mouse Phenotype	MP:0010768	mortality/aging	24	4.155501e-1	1.000000e+0	1.000000e+0	2.406449e+0	4.155501e-1	1	4.155501e-1	1.000000e+0	24	3.982479e-1	1.000000e+0	1.000000e+0	2.229486e+0	4.485339e-1	1	4046	5.000000e-1	2.471577e-4	unnamed	PALLD
Mouse Phenotype	MP:0000001	mammalian phenotype	25	6.422596e-1	1.000000e+0	1.000000e+0	1.557003e+0	6.422596e-1	1	6.422596e-1	1.000000e+0	25	6.601828e-1	1.000000e+0	1.000000e+0	1.198897e+0	8.341001e-1	1	7524	5.000000e-1	1.329080e-4	unnamed	PALLD
Disease Ontology	DOID:1520	colon carcinoma	1	1.597372e-2	1.000000e+0	1.000000e+0	6.260281e+1	1.597372e-2	1	1.597372e-2	1.000000e+0	1	1.513038e-2	1.000000e+0	1.000000e+0	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	PALLD
Disease Ontology	DOID:235	colonic neoplasm	2	1.646855e-2	1.000000e+0	1.000000e+0	6.072181e+1	1.646855e-2	1	1.646855e-2	1.000000e+0	2	1.601034e-2	1.000000e+0	1.000000e+0	6.221034e+1	1.607450e-2	1	145	5.000000e-1	6.896552e-3	unnamed	PALLD
Disease Ontology	DOID:234	colon adenocarcinoma	3	1.743321e-2	1.000000e+0	1.000000e+0	5.736179e+1	1.743321e-2	1	1.743321e-2	1.000000e+0	3	1.677999e-2	1.000000e+0	1.000000e+0	5.934539e+1	1.685051e-2	1	152	5.000000e-1	6.578947e-3	unnamed	PALLD
Disease Ontology	DOID:1997	large Intestine adenocarcinoma	4	1.779600e-2	1.000000e+0	1.000000e+0	5.619241e+1	1.779600e-2	1	1.779600e-2	1.000000e+0	5	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	PALLD
Disease Ontology	DOID:4074	pancreas adenocarcinoma	5	1.811257e-2	1.000000e+0	1.000000e+0	5.521029e+1	1.811257e-2	1	1.811257e-2	1.000000e+0	4	1.699983e-2	1.000000e+0	1.000000e+0	5.857468e+1	1.707222e-2	1	154	5.000000e-1	6.493506e-3	unnamed	PALLD
Disease Ontology	DOID:4905	pancreatic carcinoma	6	2.590130e-2	1.000000e+0	1.000000e+0	3.860810e+1	2.590130e-2	1	2.590130e-2	1.000000e+0	6	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	PALLD
Disease Ontology	DOID:1936	atherosclerosis	7	3.199454e-2	1.000000e+0	1.000000e+0	3.125533e+1	3.199454e-2	1	3.199454e-2	1.000000e+0	7	3.679384e-2	1.000000e+0	1.000000e+0	2.692687e+1	3.713763e-2	1	335	5.000000e-1	2.985075e-3	unnamed	PALLD
Disease Ontology	DOID:2348	arteriosclerotic cardiovascular disease	8	3.203444e-2	1.000000e+0	1.000000e+0	3.121640e+1	3.203444e-2	1	3.203444e-2	1.000000e+0	8	3.690264e-2	1.000000e+0	1.000000e+0	2.684673e+1	3.724849e-2	1	336	5.000000e-1	2.976190e-3	unnamed	PALLD
Disease Ontology	DOID:2349	arteriosclerosis	9	3.511376e-2	1.000000e+0	1.000000e+0	2.847886e+1	3.511376e-2	1	3.511376e-2	1.000000e+0	9	3.962064e-2	1.000000e+0	1.000000e+0	2.498753e+1	4.001995e-2	1	361	5.000000e-1	2.770083e-3	unnamed	PALLD
Disease Ontology	DOID:2868	arterial occlusive disease	10	3.554737e-2	1.000000e+0	1.000000e+0	2.813148e+1	3.554737e-2	1	3.554737e-2	1.000000e+0	10	4.048959e-2	1.000000e+0	1.000000e+0	2.444580e+1	4.090682e-2	1	369	5.000000e-1	2.710027e-3	unnamed	PALLD
Disease Ontology	DOID:2869	arteriopathy	11	3.890202e-2	1.000000e+0	1.000000e+0	2.570561e+1	3.890202e-2	1	3.890202e-2	1.000000e+0	13	4.472009e-2	1.000000e+0	1.000000e+0	2.210907e+1	4.523031e-2	1	408	5.000000e-1	2.450980e-3	unnamed	PALLD
Disease Ontology	DOID:3119	gastrointestinal neoplasm	12	4.370194e-2	1.000000e+0	1.000000e+0	2.288228e+1	4.370194e-2	1	4.370194e-2	1.000000e+0	11	4.211781e-2	1.000000e+0	1.000000e+0	2.349089e+1	4.256970e-2	1	384	5.000000e-1	2.604167e-3	unnamed	PALLD
Disease Ontology	DOID:8377	digestive system cancer	13	4.455231e-2	1.000000e+0	1.000000e+0	2.244552e+1	4.455231e-2	1	4.455231e-2	1.000000e+0	12	4.255177e-2	1.000000e+0	1.000000e+0	2.324871e+1	4.301314e-2	1	388	5.000000e-1	2.577320e-3	unnamed	PALLD
Disease Ontology	DOID:1994	large Intestine carcinoma	14	8.851868e-2	1.000000e+0	1.000000e+0	1.129705e+1	8.851868e-2	1	8.851868e-2	1.000000e+0	14	8.587513e-2	1.000000e+0	1.000000e+0	1.138952e+1	8.780001e-2	1	792	5.000000e-1	1.262626e-3	unnamed	PALLD
Disease Ontology	DOID:178	vascular disease	15	1.205522e-1	1.000000e+0	1.000000e+0	8.295164e+0	1.205522e-1	1	1.205522e-1	1.000000e+0	15	1.288165e-1	1.000000e+0	1.000000e+0	7.504576e+0	1.332520e-1	1	1202	5.000000e-1	8.319468e-4	unnamed	PALLD
Disease Ontology	DOID:4241	malignant neoplasm of breast	16	1.689834e-1	1.000000e+0	1.000000e+0	5.917740e+0	1.689834e-1	1	1.689834e-1	1.000000e+0	16	1.624258e-1	1.000000e+0	1.000000e+0	5.895752e+0	1.696137e-1	1	1530	5.000000e-1	6.535948e-4	unnamed	PALLD
Disease Ontology	DOID:3937	malignant neoplasm of thorax	17	1.691008e-1	1.000000e+0	1.000000e+0	5.913634e+0	1.691008e-1	1	1.691008e-1	1.000000e+0	17	1.626287e-1	1.000000e+0	1.000000e+0	5.888055e+0	1.698354e-1	1	1532	5.000000e-1	6.527415e-4	unnamed	PALLD
Disease Ontology	DOID:5093	thoracic cancer	18	1.702657e-1	1.000000e+0	1.000000e+0	5.873173e+0	1.702657e-1	1	1.702657e-1	1.000000e+0	18	1.639470e-1	1.000000e+0	1.000000e+0	5.838511e+0	1.712765e-1	1	1545	5.000000e-1	6.472492e-4	unnamed	PALLD
Disease Ontology	DOID:299	adenocarcinoma	19	1.706462e-1	1.000000e+0	1.000000e+0	5.860077e+0	1.706462e-1	1	1.706462e-1	1.000000e+0	20	1.699169e-1	1.000000e+0	1.000000e+0	5.623753e+0	1.778172e-1	1	1604	5.000000e-1	6.234414e-4	unnamed	PALLD
Disease Ontology	DOID:1612	mammary cancer	20	1.772500e-1	1.000000e+0	1.000000e+0	5.641748e+0	1.772500e-1	1	1.772500e-1	1.000000e+0	19	1.677945e-1	1.000000e+0	1.000000e+0	5.698358e+0	1.754892e-1	1	1583	5.000000e-1	6.317119e-4	unnamed	PALLD
Disease Ontology	DOID:197	glandular cell epithelial neoplasm	21	1.860840e-1	1.000000e+0	1.000000e+0	5.373918e+0	1.860840e-1	1	1.860840e-1	1.000000e+0	21	1.850986e-1	1.000000e+0	1.000000e+0	5.139886e+0	1.945568e-1	1	1755	5.000000e-1	5.698006e-4	unnamed	PALLD
Disease Ontology	DOID:193	reproductive system cancer	22	2.095200e-1	1.000000e+0	1.000000e+0	4.772814e+0	2.095200e-1	1	2.095200e-1	1.000000e+0	22	2.033098e-1	1.000000e+0	1.000000e+0	4.654541e+0	2.148440e-1	1	1938	5.000000e-1	5.159959e-4	unnamed	PALLD
Disease Ontology	DOID:157	epithelial carcinoma	23	2.158701e-1	1.000000e+0	1.000000e+0	4.632416e+0	2.158701e-1	1	2.158701e-1	1.000000e+0	23	2.169067e-1	1.000000e+0	1.000000e+0	4.345135e+0	2.301425e-1	1	2076	5.000000e-1	4.816956e-4	unnamed	PALLD
Disease Ontology	DOID:1287	cardiovascular system disease	24	2.464292e-1	1.000000e+0	1.000000e+0	4.057961e+0	2.464292e-1	1	2.464292e-1	1.000000e+0	24	2.586189e-1	1.000000e+0	1.000000e+0	3.598125e+0	2.779225e-1	1	2507	5.000000e-1	3.988831e-4	unnamed	PALLD
Disease Ontology	DOID:305	carcinoma	25	3.218892e-1	1.000000e+0	1.000000e+0	3.106659e+0	3.218892e-1	1	3.218892e-1	1.000000e+0	25	3.253901e-1	1.000000e+0	1.000000e+0	2.798790e+0	3.572973e-1	1	3223	5.000000e-1	3.102699e-4	unnamed	PALLD
Disease Ontology	DOID:462	cancer by anatomical entity	26	3.485076e-1	1.000000e+0	1.000000e+0	2.869378e+0	3.485076e-1	1	3.485076e-1	1.000000e+0	26	3.467081e-1	1.000000e+0	1.000000e+0	2.607835e+0	3.834599e-1	1	3459	5.000000e-1	2.891009e-4	unnamed	PALLD
Disease Ontology	DOID:162	cancer	27	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	27	4.854768e-1	1.000000e+0	1.000000e+0	1.768725e+0	5.653789e-1	1	5100	5.000000e-1	1.960784e-4	unnamed	PALLD
Disease Ontology	DOID:7	disease of anatomical entity	28	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	28	5.469036e-1	1.000000e+0	1.000000e+0	1.529676e+0	6.537332e-1	1	5897	5.000000e-1	1.695778e-4	unnamed	PALLD
Disease Ontology	DOID:4	disease	29	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	29	6.831746e-1	1.000000e+0	1.000000e+0	1.143863e+0	8.742309e-1	1	7886	5.000000e-1	1.268070e-4	unnamed	PALLD
MSigDB Cancer Neighborhood	MORF_CDC16	Neighborhood of CDC16	1	5.710785e-3	1.000000e+0	1.000000e+0	1.751073e+2	5.710785e-3	1	5.710785e-3	1.000000e+0	1	7.745261e-3	1.000000e+0	1.000000e+0	1.288643e+2	7.760102e-3	1	70	5.000000e-1	1.428571e-2	unnamed	CBR4
MSigDB Cancer Neighborhood	MORF_PPP1CC	Neighborhood of PPP1CC	2	1.291401e-2	1.000000e+0	1.000000e+0	7.743529e+1	1.291401e-2	1	1.291401e-2	1.000000e+0	2	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	CBR4
Placenta Disorders	00003	Genes with SNPs significantly associated with pre-eclampsia	1	9.168487e-3	2.750546e-2	2.750546e-2	1.090693e+2	9.168487e-3	1	9.168487e-3	1.000000e+0	1	9.952663e-3	2.985799e-2	2.985799e-2	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	PALLD
Placenta Disorders	00002	Genes with SNPs studied in association with pre-eclampsia	2	1.556817e-2	4.670451e-2	2.335225e-2	6.423364e+1	1.556817e-2	1	1.556817e-2	1.000000e+0	2	1.645017e-2	4.935051e-2	2.467526e-2	6.054027e+1	1.651793e-2	1	149	5.000000e-1	6.711409e-3	unnamed	PALLD
MGI Expression: Detected	428	TS13_neural ectoderm	1	6.945935e-2	1.000000e+0	1.000000e+0	1.439691e+1	6.945935e-2	1	6.945935e-2	1.000000e+0	1	4.320252e-2	1.000000e+0	1.000000e+0	2.289467e+1	4.367829e-2	1	394	5.000000e-1	2.538071e-3	unnamed	PALLD
MGI Expression: Detected	427	TS13_embryo ectoderm	2	7.177951e-2	1.000000e+0	1.000000e+0	1.393155e+1	7.177951e-2	1	7.177951e-2	1.000000e+0	2	4.515346e-2	1.000000e+0	1.000000e+0	2.189442e+1	4.567374e-2	1	412	5.000000e-1	2.427184e-3	unnamed	PALLD
MGI Expression: Detected	415	TS13_embryo	3	1.867453e-1	1.000000e+0	1.000000e+0	5.354887e+0	1.867453e-1	1	1.867453e-1	1.000000e+0	3	1.591759e-1	1.000000e+0	1.000000e+0	6.021696e+0	1.660662e-1	1	1498	5.000000e-1	6.675567e-4	unnamed	PALLD
MGI Expression: Detected	414	Theiler_stage_13	4	1.906274e-1	1.000000e+0	1.000000e+0	5.245836e+0	1.906274e-1	1	1.906274e-1	1.000000e+0	4	1.649603e-1	1.000000e+0	1.000000e+0	5.800965e+0	1.723851e-1	1	1555	5.000000e-1	6.430868e-4	unnamed	PALLD
MGI Expression: Detected	1016	TS15_embryo	5	2.533670e-1	1.000000e+0	1.000000e+0	3.946844e+0	2.533670e-1	1	2.533670e-1	1.000000e+0	5	2.237590e-1	1.000000e+0	1.000000e+0	4.203402e+0	2.379026e-1	1	2146	5.000000e-1	4.659832e-4	unnamed	PALLD
MGI Expression: Detected	1015	Theiler_stage_15	6	2.573675e-1	1.000000e+0	1.000000e+0	3.885495e+0	2.573675e-1	1	2.573675e-1	1.000000e+0	6	2.277584e-1	1.000000e+0	1.000000e+0	4.124600e+0	2.424478e-1	1	2187	5.000000e-1	4.572474e-4	unnamed	PALLD
MGI Expression: Detected	2023	TS17_embryo	7	3.504112e-1	1.000000e+0	1.000000e+0	2.853790e+0	3.504112e-1	1	3.504112e-1	1.000000e+0	7	3.281190e-1	1.000000e+0	1.000000e+0	2.772979e+0	3.606230e-1	1	3253	5.000000e-1	3.074085e-4	unnamed	PALLD
MGI Expression: Detected	2022	Theiler_stage_17	8	3.517739e-1	1.000000e+0	1.000000e+0	2.842735e+0	3.517739e-1	1	3.517739e-1	1.000000e+0	8	3.303888e-1	1.000000e+0	1.000000e+0	2.751830e+0	3.633945e-1	1	3278	5.000000e-1	3.050641e-4	unnamed	PALLD
MSigDB Perturbation	CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP	Genes specifically up-regulated in pediadric acute lymphoblastic leukemia (ALL) patients by mercaptopurine [PubChem=667490].	1	7.959990e-4	1.000000e+0	1.000000e+0	1.256283e+3	7.959990e-4	1	7.959990e-4	1.000000e+0	2	1.440682e-3	1.000000e+0	1.000000e+0	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	CBR4
MSigDB Perturbation	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	Genes down-regulated in the RCC4 cells (renal cell carcinoma, RCC) expressing VHL [GeneID=7428] mutants Type 1 and 2B (associated with RCC) but not those of Type 2A and 2C (not associated with RCC).	2	1.702973e-3	1.000000e+0	1.000000e+0	5.872084e+2	1.702973e-3	1	1.702973e-3	1.000000e+0	3	1.662234e-3	1.000000e+0	1.000000e+0	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	PALLD
MSigDB Perturbation	OXFORD_RALA_OR_RALB_TARGETS_DN	Genes down-regulated after knockdown of RALA or RALB [GeneiD=5898;5899], which were also differentially expressed in bladder cancer compared to normal bladder urothelium tissue.	3	2.268395e-3	1.000000e+0	1.000000e+0	4.408404e+2	2.268395e-3	1	2.268395e-3	1.000000e+0	4	2.658910e-3	1.000000e+0	1.000000e+0	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	PALLD
MSigDB Perturbation	MILI_PSEUDOPODIA	Transcripts significantly enriched in pseudopodia of NIH/3T3 cells (fibroblast) in response to both chemotactic (lysophosphatidic acid, LPA [PubChem=3988]) and haptotactic (fibronectin, FN1 [GeneID=2335) migratory stimuli.	4	3.368256e-3	1.000000e+0	1.000000e+0	2.968896e+2	3.368256e-3	1	3.368256e-3	1.000000e+0	6	4.650770e-3	1.000000e+0	1.000000e+0	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	PALLD
MSigDB Perturbation	LIU_TARGETS_OF_VMYB_VS_CMYB_DN	Gene regulated in the opposite directions by v-MYB (DN) and c-MYB  (UP) variants of CMYB [GeneID=4602] overexpressed in primary monocyte cultures off adenoviral vectors.	5	4.606587e-3	1.000000e+0	1.000000e+0	2.170805e+2	4.606587e-3	1	4.606587e-3	1.000000e+0	5	4.318932e-3	1.000000e+0	1.000000e+0	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	PALLD
MSigDB Perturbation	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	Down-regulated genes in hepatocellular  carcinoma (HCC) subclass G123, defined by unsupervised clustering.	6	5.172754e-3	1.000000e+0	1.000000e+0	1.933206e+2	5.172754e-3	1	5.172754e-3	1.000000e+0	8	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	CBR4
MSigDB Perturbation	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	Genes down-regulated in hematopoietic progenitor cells (HPC) of T lymphocyte and NK (natural killer) lineage.	7	6.057800e-3	1.000000e+0	1.000000e+0	1.650764e+2	6.057800e-3	1	6.057800e-3	1.000000e+0	9	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	PALLD
MSigDB Perturbation	MILI_PSEUDOPODIA_CHEMOTAXIS_UP	Transcripts enriched in pseudopodia of NIH/3T3 cells (fibroblast) in response to the chemotactic migration stimulus by lysophosphatidic acid (LPA) [PubChem=3988].	8	6.828353e-3	1.000000e+0	1.000000e+0	1.464482e+2	6.828353e-3	1	6.828353e-3	1.000000e+0	10	7.855690e-3	1.000000e+0	1.000000e+0	1.270493e+2	7.870961e-3	1	71	5.000000e-1	1.408451e-2	unnamed	PALLD
MSigDB Perturbation	TOOKER_GEMCITABINE_RESISTANCE_UP	Up-regulated genes in Calu3 cells (non-small cell lung cancer, NSCLC) resistant to gemcitabine [PubChem=3461] which became down-regulated in response to bexarotene [PubChem=82146].	9	6.991378e-3	1.000000e+0	1.000000e+0	1.430333e+2	6.991378e-3	1	6.991378e-3	1.000000e+0	13	8.738896e-3	1.000000e+0	1.000000e+0	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	PALLD
MSigDB Perturbation	MCBRYAN_PUBERTAL_BREAST_6_7WK_DN	Genes down-regulated during pubertal mammary gland development between week 6 and 7.	10	7.786123e-3	1.000000e+0	1.000000e+0	1.284336e+2	7.786123e-3	1	7.786123e-3	1.000000e+0	12	8.518131e-3	1.000000e+0	1.000000e+0	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	PALLD
MSigDB Perturbation	WALLACE_PROSTATE_CANCER_RACE_DN	Genes down-regulated in prostate cancer samples from African-American patients compared to those from the European-American patients.	11	8.533489e-3	1.000000e+0	1.000000e+0	1.171854e+2	8.533489e-3	1	8.533489e-3	1.000000e+0	13	8.738896e-3	1.000000e+0	1.000000e+0	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	CBR4
MSigDB Perturbation	ROSS_LEUKEMIA_WITH_MLL_FUSIONS	Top 100 probe sets associated with MLL fusions [GeneID=4297] irrespective of the lineage of the pediatric acute leukemia.	12	8.750573e-3	1.000000e+0	1.000000e+0	1.142782e+2	8.750573e-3	1	8.750573e-3	1.000000e+0	11	8.407740e-3	1.000000e+0	1.000000e+0	1.186908e+2	8.425254e-3	1	76	5.000000e-1	1.315789e-2	unnamed	PALLD
MSigDB Perturbation	ZHAN_MULTIPLE_MYELOMA_MS_UP	Top 50 up-regulated genes in cluster MS of multiple myeloma samples with characteristic expression spike of WHSC1 [GeneID=7468].	13	9.953672e-3	1.000000e+0	1.000000e+0	1.004654e+2	9.953672e-3	1	9.953672e-3	1.000000e+0	7	4.871965e-3	1.000000e+0	1.000000e+0	2.050114e+2	4.877778e-3	1	44	5.000000e-1	2.272727e-2	unnamed	PALLD
MSigDB Perturbation	LEE_EARLY_T_LYMPHOCYTE_UP	Genes up-regulated at early stages of progenitor T lymphocyte maturation compared to the late stages.	14	1.079646e-2	1.000000e+0	1.000000e+0	9.262291e+1	1.079646e-2	1	1.079646e-2	1.000000e+0	18	1.149638e-2	1.000000e+0	1.000000e+0	8.673558e+1	1.152929e-2	1	104	5.000000e-1	9.615385e-3	unnamed	PALLD
MSigDB Perturbation	LAIHO_COLORECTAL_CANCER_SERRATED_UP	Genes up-regulated in serrated vs conventional colorectal carcinoma (CRC) samples.	15	1.251101e-2	1.000000e+0	1.000000e+0	7.992959e+1	1.251101e-2	1	1.251101e-2	1.000000e+0	19	1.226779e-2	1.000000e+0	1.000000e+0	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	PALLD
MSigDB Perturbation	SWEET_KRAS_TARGETS_UP	Genes upregulated in KRAS [GeneID=3845] knockdown vs control in a human cell line.	16	1.287833e-2	1.000000e+0	1.000000e+0	7.764982e+1	1.287833e-2	1	1.287833e-2	1.000000e+0	15	9.180352e-3	1.000000e+0	1.000000e+0	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	PALLD
MSigDB Perturbation	HOEBEKE_LYMPHOID_STEM_CELL_UP	Genes up-regulated in the common lymphoid progenitor (CLP, defined as CD34+CD38-CD7+ [GeneID=947;952;924]) compared to a multipotent cord blood cell (defined as CD34+CD38+CD7-).	17	1.301443e-2	1.000000e+0	1.000000e+0	7.683779e+1	1.301443e-2	1	1.301443e-2	1.000000e+0	16	9.732033e-3	1.000000e+0	1.000000e+0	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	PALLD
MSigDB Perturbation	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	Up-regulated genes whose expression profile is specific to Custer I of urothelial cell carcinoma (UCC) tumors.	18	1.426584e-2	1.000000e+0	1.000000e+0	7.009751e+1	1.426584e-2	1	1.426584e-2	1.000000e+0	20	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	CBR4
MSigDB Perturbation	YAGI_AML_WITH_T_9_11_TRANSLOCATION	Genes specifically expressed in samples from patients with pediatric acute myeloid leukemia (AML) bearing t(9;11) translocation.	19	1.504705e-2	1.000000e+0	1.000000e+0	6.645822e+1	1.504705e-2	1	1.504705e-2	1.000000e+0	27	1.590037e-2	1.000000e+0	1.000000e+0	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	PALLD
MSigDB Perturbation	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	Genes whose expression profile is specific to Cluster IIa of urothelial cell carcinoma (UCC) tumors.	20	1.559721e-2	1.000000e+0	1.000000e+0	6.411401e+1	1.559721e-2	1	1.559721e-2	1.000000e+0	24	1.491033e-2	1.000000e+0	1.000000e+0	6.681852e+1	1.496591e-2	1	135	5.000000e-1	7.407407e-3	unnamed	PALLD
MSigDB Perturbation	PODAR_RESPONSE_TO_ADAPHOSTIN_UP	Up-regulated genes in MM1.S cells (multiple myeloma) treated with adaphostin [PubChem=387042], a tyrosine kinase inhibitor with anticancer properties.	21	1.677436e-2	1.000000e+0	1.000000e+0	5.961480e+1	1.677436e-2	1	1.677436e-2	1.000000e+0	28	1.612031e-2	1.000000e+0	1.000000e+0	6.178425e+1	1.618536e-2	1	146	5.000000e-1	6.849315e-3	unnamed	PALLD
MSigDB Perturbation	WEI_MIR34A_TARGETS	Potential direct target genes for MIR34A [GeneID=407040] microRNA in IMR32 cells (neuroblastoma).	22	1.786648e-2	1.000000e+0	1.000000e+0	5.597073e+1	1.786648e-2	1	1.786648e-2	1.000000e+0	25	1.513038e-2	1.000000e+0	1.000000e+0	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	PALLD
MSigDB Perturbation	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN	Genes down-regulated in RWPE-1 cells (prostate cancer) upon expression of constitutively active form of STAT3 [GeneID=6774].	23	1.813081e-2	1.000000e+0	1.000000e+0	5.515473e+1	1.813081e-2	1	1.813081e-2	1.000000e+0	22	1.303889e-2	1.000000e+0	1.000000e+0	7.644492e+1	1.308131e-2	1	118	5.000000e-1	8.474576e-3	unnamed	PALLD
MSigDB Perturbation	NAGASHIMA_NRG1_SIGNALING_UP	Genes up-regulated in MCF7 cells (breast cancer) after stimulation with NRG1 [GeneID=3084].	24	1.873764e-2	1.000000e+0	1.000000e+0	5.336852e+1	1.873764e-2	1	1.873764e-2	1.000000e+0	31	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	PALLD
MSigDB Perturbation	BROWNE_HCMV_INFECTION_12HR_DN	Genes down-regulated in primary fibroblast cell culture after infection with HCMV (AD169 strain) at 12 h time point that were not down-regulated at the previous time point, 10 h.	25	1.874045e-2	1.000000e+0	1.000000e+0	5.336050e+1	1.874045e-2	1	1.874045e-2	1.000000e+0	17	1.105544e-2	1.000000e+0	1.000000e+0	9.020500e+1	1.108586e-2	1	100	5.000000e-1	1.000000e-2	unnamed	CBR4
MSigDB Perturbation	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP	Genes up-regulated in SEND cells (skin endothelium) at hypoxia after knockdown of ELK3 [GeneID=2004] and HIF1A [GeneID=3091] by RNAi.	26	2.056223e-2	1.000000e+0	1.000000e+0	4.863286e+1	2.056223e-2	1	2.056223e-2	1.000000e+0	26	1.557041e-2	1.000000e+0	1.000000e+0	6.397518e+1	1.563106e-2	1	141	5.000000e-1	7.092199e-3	unnamed	PALLD
MSigDB Perturbation	LEE_NEURAL_CREST_STEM_CELL_DN	Genes down-regulated in the neural crest stem cells (NCS), defined as p75+/HNK1+ [GeneID=4804;27087].	27	2.086457e-2	1.000000e+0	1.000000e+0	4.792813e+1	2.086457e-2	1	2.086457e-2	1.000000e+0	20	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	PALLD
MSigDB Perturbation	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	Genes up-regulated in CD34+ [GeneID=947] hematopoetic cells by expression of NUP98-HOXA9 fusion [GeneID=4928;3205] off a retroviral vector at 8 days after transduction.	28	2.091328e-2	1.000000e+0	1.000000e+0	4.781650e+1	2.091328e-2	1	2.091328e-2	1.000000e+0	29	1.645017e-2	1.000000e+0	1.000000e+0	6.054027e+1	1.651793e-2	1	149	5.000000e-1	6.711409e-3	unnamed	PALLD
MSigDB Perturbation	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	Genes up-regulated in CD34+ [GeneID=947] hematopoetic cells by expression of NUP98-HOXA9 fusion [GeneID=4928;3205] off a retroviral vector at 16 days after transduction.	29	2.140041e-2	1.000000e+0	1.000000e+0	4.672808e+1	2.140041e-2	1	2.140041e-2	1.000000e+0	30	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	PALLD
MSigDB Perturbation	CHEBOTAEV_GR_TARGETS_DN	Genes down-regulated in follicular epithelial stem cells after transgenic expression of GR [GeneID=2908] under control of the keratin5 (K5) [GeneID=3852] promoter.	30	2.213472e-2	1.000000e+0	1.000000e+0	4.517790e+1	2.213472e-2	1	2.213472e-2	1.000000e+0	23	1.325916e-2	1.000000e+0	1.000000e+0	7.517083e+1	1.330303e-2	1	120	5.000000e-1	8.333333e-3	unnamed	PALLD
MSigDB Perturbation	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	Genes up-regulated in SH-SY5Y cells (neuroblastoma) after treatment with epoxomicin [PubChem=3035402], a protease inhibitor causing apoptosis.	31	2.340772e-2	1.000000e+0	1.000000e+0	4.272094e+1	2.340772e-2	1	2.340772e-2	1.000000e+0	40	2.544509e-2	1.000000e+0	1.000000e+0	3.904978e+1	2.560834e-2	1	231	5.000000e-1	4.329004e-3	unnamed	PALLD
MSigDB Perturbation	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	Genes up-regulated in normal hematopoietic progenitors by RUNX1-RUNX1T1 [GeneID=861;862] fusion.	32	2.375504e-2	1.000000e+0	1.000000e+0	4.209633e+1	2.375504e-2	1	2.375504e-2	1.000000e+0	33	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	PALLD
MSigDB Perturbation	FOURNIER_ACINAR_DEVELOPMENT_LATE_2	Genes identified by method 2 as coordinately down-regulated late in HMEC cells (mammary epithelium) during acinar development in vitro.	33	2.428098e-2	1.000000e+0	1.000000e+0	4.118451e+1	2.428098e-2	1	2.428098e-2	1.000000e+0	46	3.069123e-2	1.000000e+0	1.000000e+0	3.233154e+1	3.092955e-2	1	279	5.000000e-1	3.584229e-3	unnamed	PALLD
MSigDB Perturbation	LEI_MYB_TARGETS	Myb-regulated genes in MCF7 (breast cancer) and lung epithelial cell lines overexpressing MYBL2, MYBL1 or MYB [GeneID=4605;4603;4602].	34	2.437585e-2	1.000000e+0	1.000000e+0	4.102422e+1	2.437585e-2	1	2.437585e-2	1.000000e+0	50	3.439869e-2	1.000000e+0	1.000000e+0	2.881949e+1	3.469874e-2	1	313	5.000000e-1	3.194888e-3	unnamed	PALLD
MSigDB Perturbation	CAIRO_HEPATOBLASTOMA_UP	Genes up-regulated in hepatoblastoma samples compared to normal liver tissue.	35	2.468362e-2	1.000000e+0	1.000000e+0	4.051269e+1	2.468362e-2	1	2.468362e-2	1.000000e+0	35	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	PALLD
MSigDB Perturbation	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	Up-regulated genes from the set G (Fig. 5a): specific to cells expressing both MLL-AF4 [GeneID=4297;4299] and AF4-MLL fusion proteins.	36	2.645642e-2	1.000000e+0	1.000000e+0	3.779800e+1	2.645642e-2	1	2.645642e-2	1.000000e+0	38	2.467884e-2	1.000000e+0	1.000000e+0	4.027009e+1	2.483233e-2	1	224	5.000000e-1	4.464286e-3	unnamed	PALLD
MSigDB Perturbation	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	Genes whose expression profile is specific to Cluster III of urothelial cell carcinoma (UCC) tumors.	37	2.649167e-2	1.000000e+0	1.000000e+0	3.774772e+1	2.649167e-2	1	2.649167e-2	1.000000e+0	36	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	CBR4
MSigDB Perturbation	UDAYAKUMAR_MED1_TARGETS_DN	Genes down-regulated in HeLa cells after knockdown of MED1 [GeneID=5469] by RNAi.	38	2.734562e-2	1.000000e+0	1.000000e+0	3.656893e+1	2.734562e-2	1	2.734562e-2	1.000000e+0	39	2.478833e-2	1.000000e+0	1.000000e+0	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	PALLD
MSigDB Perturbation	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	Genes up-regulated in CD34+ [GeneID=947] hematopoetic cells by expression of NUP98-HOXA9 fusion [GeneID=4928;3205] off a retroviral vector at 10 days after transduction.	39	2.741763e-2	1.000000e+0	1.000000e+0	3.647288e+1	2.741763e-2	1	2.741763e-2	1.000000e+0	32	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	PALLD
MSigDB Perturbation	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	Up-regulated genes in peripheral zone of human pancreatic cancer growing in the pancreas of nude mice compared to that of the tumor from the central zone.	40	2.936179e-2	1.000000e+0	1.000000e+0	3.405787e+1	2.936179e-2	1	2.936179e-2	1.000000e+0	47	3.080038e-2	1.000000e+0	1.000000e+0	3.221607e+1	3.104041e-2	1	280	5.000000e-1	3.571429e-3	unnamed	PALLD
MSigDB Perturbation	DOANE_RESPONSE_TO_ANDROGEN_DN	Genes down-regulated in MDA-MB-453 cells (class A ER(-) [GeneID=2099] breast cancer) after exposure to the androgen R1881 [PubChem=13766].	41	2.973318e-2	1.000000e+0	1.000000e+0	3.363246e+1	2.973318e-2	1	2.973318e-2	1.000000e+0	40	2.544509e-2	1.000000e+0	1.000000e+0	3.904978e+1	2.560834e-2	1	231	5.000000e-1	4.329004e-3	unnamed	PALLD
MSigDB Perturbation	DOUGLAS_BMI1_TARGETS_DN	Genes down-regulated in A4573 cells (Ewing's sarcoma, ESFT) after knockdown of BMI1 [GeneID=648] by RNAi.	42	3.048740e-2	1.000000e+0	1.000000e+0	3.280044e+1	3.048740e-2	1	3.048740e-2	1.000000e+0	49	3.363597e-2	1.000000e+0	1.000000e+0	2.947876e+1	3.392273e-2	1	306	5.000000e-1	3.267974e-3	unnamed	CBR4
MSigDB Perturbation	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	Genes down-regulated in mucinous ovarian carcinoma tumors of low malignant potential (LMP) compared to normal ovarian surface epithelium tissue.	43	3.179749e-2	1.000000e+0	1.000000e+0	3.144903e+1	3.179749e-2	1	3.179749e-2	1.000000e+0	34	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	CBR4
MSigDB Perturbation	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP	Genes up-regulated during pubertal mammary gland development between week 4 and 5.	44	3.235801e-2	1.000000e+0	1.000000e+0	3.090425e+1	3.235801e-2	1	3.235801e-2	1.000000e+0	44	2.905334e-2	1.000000e+0	1.000000e+0	3.416856e+1	2.926667e-2	1	264	5.000000e-1	3.787879e-3	unnamed	PALLD
MSigDB Perturbation	LU_AGING_BRAIN_UP	Age up-regulated genes in the human frontal cortex.	45	3.536144e-2	1.000000e+0	1.000000e+0	2.827939e+1	3.536144e-2	1	3.536144e-2	1.000000e+0	42	2.817922e-2	1.000000e+0	1.000000e+0	3.523633e+1	2.837980e-2	1	256	5.000000e-1	3.906250e-3	unnamed	PALLD
MSigDB Perturbation	RIGGINS_TAMOXIFEN_RESISTANCE_DN	Genes down-regulated SUM44/LCCTam cells (breast cancer) resistant to 4-hydroxytamoxifen [PubChem=63062] relative to the parental SUM44 cells sensitive to the drug.	46	3.564052e-2	1.000000e+0	1.000000e+0	2.805795e+1	3.564052e-2	1	3.564052e-2	1.000000e+0	36	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	PALLD
MSigDB Perturbation	GARY_CD5_TARGETS_DN	Genes down-regulated in Daudi cells (B lymphocytes) stably expressing CD5 [GeneID=921] off a plasmid vector.	47	3.783698e-2	1.000000e+0	1.000000e+0	2.642917e+1	3.783698e-2	1	3.783698e-2	1.000000e+0	56	4.612818e-2	1.000000e+0	1.000000e+0	2.142637e+1	4.667147e-2	1	421	5.000000e-1	2.375297e-3	unnamed	PALLD
MSigDB Perturbation	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP	Genes whose promoters display higher levels of histone H3 trimethylation mark at K27 (H3K27me3) in hepatocellular carcinoma (HCC) compared to normal liver.	48	3.869343e-2	1.000000e+0	1.000000e+0	2.584418e+1	3.869343e-2	1	3.869343e-2	1.000000e+0	43	2.872559e-2	1.000000e+0	1.000000e+0	3.456130e+1	2.893409e-2	1	261	5.000000e-1	3.831418e-3	unnamed	PALLD
MSigDB Perturbation	MOHANKUMAR_TLX1_TARGETS_UP	Up-regulated in MCF7 cells (breast cancer) by TLX1 (HOX11) [GeneID=3195].	49	3.940953e-2	1.000000e+0	1.000000e+0	2.537457e+1	3.940953e-2	1	3.940953e-2	1.000000e+0	57	4.634471e-2	1.000000e+0	1.000000e+0	2.132506e+1	4.689319e-2	1	423	5.000000e-1	2.364066e-3	unnamed	PALLD
MSigDB Perturbation	GABRIELY_MIR21_TARGETS	Genes significantly de-regulated (p &lt; 0.05) by MIR21 [GeneID=406991] in A172 cells (glioma).	50	4.148238e-2	1.000000e+0	1.000000e+0	2.410662e+1	4.148238e-2	1	4.148238e-2	1.000000e+0	45	3.014542e-2	1.000000e+0	1.000000e+0	3.292153e+1	3.037526e-2	1	274	5.000000e-1	3.649635e-3	unnamed	PALLD
MSigDB Perturbation	LU_EZH2_TARGETS_DN	Genes down-regulated in SKOV3ip1 cells (ovarian cancer) upon knockdown of EZH2 [GeneID=2146] by RNAi.	51	4.532625e-2	1.000000e+0	1.000000e+0	2.206227e+1	4.532625e-2	1	4.532625e-2	1.000000e+0	52	4.124960e-2	1.000000e+0	1.000000e+0	2.399069e+1	4.168283e-2	1	376	5.000000e-1	2.659574e-3	unnamed	PALLD
MSigDB Perturbation	LINDGREN_BLADDER_CANCER_CLUSTER_2B	Genes specifically up-regulated in Cluster IIb of urothelial cell carcinom (UCC) tumors.	52	4.661543e-2	1.000000e+0	1.000000e+0	2.145212e+1	4.661543e-2	1	4.661543e-2	1.000000e+0	53	4.168376e-2	1.000000e+0	1.000000e+0	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	PALLD
MSigDB Perturbation	PASINI_SUZ12_TARGETS_DN	Genes down-regulated in ES (embryonic stem cells) with defficient SUZ12 [GeneID=23512].	53	4.851555e-2	1.000000e+0	1.000000e+0	2.061195e+1	4.851555e-2	1	4.851555e-2	1.000000e+0	48	3.352698e-2	1.000000e+0	1.000000e+0	2.957541e+1	3.381187e-2	1	305	5.000000e-1	3.278689e-3	unnamed	PALLD
MSigDB Perturbation	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	Genes up-regulated during later stage of differentiation of Oli-Neu cells (oligodendroglial precursor) in response to PD174265 [PubChemID=4709].	54	4.971953e-2	1.000000e+0	1.000000e+0	2.011282e+1	4.971953e-2	1	4.971953e-2	1.000000e+0	69	5.961449e-2	1.000000e+0	1.000000e+0	1.652106e+1	6.052880e-2	1	546	5.000000e-1	1.831502e-3	unnamed	PALLD
MSigDB Perturbation	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	Genes up-regulated in invasive ductal carcinoma (IDC) relative to ductal carcinoma in situ (DCIS, non-invasive).	55	5.284057e-2	1.000000e+0	1.000000e+0	1.892485e+1	5.284057e-2	1	5.284057e-2	1.000000e+0	51	3.799030e-2	1.000000e+0	1.000000e+0	2.607081e+1	3.835708e-2	1	346	5.000000e-1	2.890173e-3	unnamed	PALLD
MSigDB Perturbation	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP	Genes up-regulated in macrophage by live P.gingivalis.	56	5.350410e-2	1.000000e+0	1.000000e+0	1.869016e+1	5.350410e-2	1	5.350410e-2	1.000000e+0	55	4.591162e-2	1.000000e+0	1.000000e+0	2.152864e+1	4.644975e-2	1	419	5.000000e-1	2.386635e-3	unnamed	PALLD
MSigDB Perturbation	MILI_PSEUDOPODIA_HAPTOTAXIS_UP	Transcripts enriched in pseudopodia of NIH/3T3 cells (fibroblast) in response to haptotactic migratory stimulus by fibronectin, FN1 [GeneID=2335].	57	5.651646e-2	1.000000e+0	1.000000e+0	1.769396e+1	5.651646e-2	1	5.651646e-2	1.000000e+0	64	5.455490e-2	1.000000e+0	1.000000e+0	1.807715e+1	5.531844e-2	1	499	5.000000e-1	2.004008e-3	unnamed	PALLD
MSigDB Perturbation	BAELDE_DIABETIC_NEPHROPATHY_DN	Genes down-regulated in glomeruli of kidneys from patients with diabetic nephropathy (type 2 diabetes mellitus).	58	5.861782e-2	1.000000e+0	1.000000e+0	1.705966e+1	5.861782e-2	1	5.861782e-2	1.000000e+0	58	4.666947e-2	1.000000e+0	1.000000e+0	2.117488e+1	4.722576e-2	1	426	5.000000e-1	2.347418e-3	unnamed	PALLD
MSigDB Perturbation	LIU_PROSTATE_CANCER_DN	Genes down-regulated in prostate cancer samples.	59	5.894800e-2	1.000000e+0	1.000000e+0	1.696410e+1	5.894800e-2	1	5.894800e-2	1.000000e+0	59	4.958982e-2	1.000000e+0	1.000000e+0	1.991280e+1	5.021895e-2	1	453	5.000000e-1	2.207506e-3	unnamed	PALLD
MSigDB Perturbation	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	The 'group 1 set' of genes associated with acquired endocrine therapy resistance in breast tumors expressing ESR1 and ERBB2 [GeneID=2099;2064].	60	5.895188e-2	1.000000e+0	1.000000e+0	1.696299e+1	5.895188e-2	1	5.895188e-2	1.000000e+0	62	5.433930e-2	1.000000e+0	1.000000e+0	1.814990e+1	5.509672e-2	1	497	5.000000e-1	2.012072e-3	unnamed	PALLD
MSigDB Perturbation	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	Genes up-regulated in kidney biopsies from patients with well functioning kidneys more than 1-year post transplant compared to the biopsies from normal living kidney donors.	61	5.987193e-2	1.000000e+0	1.000000e+0	1.670232e+1	5.987193e-2	1	5.987193e-2	1.000000e+0	1	9.176622e-4	1.000000e+0	1.000000e+0	3.298172e+1	6.063965e-2	2	547	1.000000e+0	3.656307e-3	unnamed	CBR4,PALLD
MSigDB Perturbation	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF	Class I of genes transiently induced by EGF [GeneID =1950] in 184A1 cells (mammary epithelium).	62	6.194948e-2	1.000000e+0	1.000000e+0	1.614218e+1	6.194948e-2	1	6.194948e-2	1.000000e+0	60	5.272149e-2	1.000000e+0	1.000000e+0	1.871473e+1	5.343385e-2	1	482	5.000000e-1	2.074689e-3	unnamed	PALLD
MSigDB Perturbation	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	Genes down-regulated in the urogenital sinus (UGS) of day E16 females exposed to the androgen dihydrotestosterone [PubChem=10635] for 6 h.	63	6.223242e-2	1.000000e+0	1.000000e+0	1.606879e+1	6.223242e-2	1	6.223242e-2	1.000000e+0	66	5.638653e-2	1.000000e+0	1.000000e+0	1.748159e+1	5.720304e-2	1	516	5.000000e-1	1.937984e-3	unnamed	PALLD
MSigDB Perturbation	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	Genes down-regulated in kidney biopsies from patients with acute transplant rejection compared to the biopsies from patients with well functioning kidneys more than 1-year post transplant.	64	6.264225e-2	1.000000e+0	1.000000e+0	1.596367e+1	6.264225e-2	1	6.264225e-2	1.000000e+0	67	5.929194e-2	1.000000e+0	1.000000e+0	1.661234e+1	6.019622e-2	1	543	5.000000e-1	1.841621e-3	unnamed	CBR4
MSigDB Perturbation	ONKEN_UVEAL_MELANOMA_DN	Genes down-regulated in uveal melanoma: class 2 vs class 1 tumors.	65	6.267829e-2	1.000000e+0	1.000000e+0	1.595449e+1	6.267829e-2	1	6.267829e-2	1.000000e+0	65	5.574028e-2	1.000000e+0	1.000000e+0	1.768725e+1	5.653789e-2	1	510	5.000000e-1	1.960784e-3	unnamed	PALLD
MSigDB Perturbation	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN	Genes down-regulated in anaplastic thyroid carcinoma (ATC) compared to normal thyroid tissue.	66	6.444202e-2	1.000000e+0	1.000000e+0	1.551783e+1	6.444202e-2	1	6.444202e-2	1.000000e+0	61	5.293728e-2	1.000000e+0	1.000000e+0	1.863740e+1	5.365556e-2	1	484	5.000000e-1	2.066116e-3	unnamed	CBR4
MSigDB Perturbation	CHICAS_RB1_TARGETS_CONFLUENT	Genes up-regulated in confluent IMR90 cells (fibroblast) after knockdown of RB1 [GeneID=5925] by RNAi.	67	7.290419e-2	1.000000e+0	1.000000e+0	1.371663e+1	7.290419e-2	1	7.290419e-2	1.000000e+0	68	5.939946e-2	1.000000e+0	1.000000e+0	1.658180e+1	6.030708e-2	1	544	5.000000e-1	1.838235e-3	unnamed	PALLD
MSigDB Perturbation	SCHLOSSER_SERUM_RESPONSE_DN	Cluster 4: genes down-regulated in B493-6 cells (B lymphocytes) upon serum stimulation but not affected by MYC [GeneID=4609].	68	7.399847e-2	1.000000e+0	1.000000e+0	1.351379e+1	7.399847e-2	1	7.399847e-2	1.000000e+0	71	7.524493e-2	1.000000e+0	1.000000e+0	1.303540e+1	7.671415e-2	1	692	5.000000e-1	1.445087e-3	unnamed	CBR4
MSigDB Perturbation	HAMAI_APOPTOSIS_VIA_TRAIL_UP	Genes up-regulated in T1 cells (primary melanoma, sensitive to TRAIL [GeneID=8743]) compared to G1 cells (metastatic melanoma, resistant to TRAIL).	69	7.409110e-2	1.000000e+0	1.000000e+0	1.349690e+1	7.409110e-2	1	7.409110e-2	1.000000e+0	70	6.144121e-2	1.000000e+0	1.000000e+0	1.602220e+1	6.241339e-2	1	563	5.000000e-1	1.776199e-3	unnamed	PALLD
MSigDB Perturbation	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	Genes down-regulated in MCF7 cells (breast cancer) at 24 h of estradiol [PubChemID=5757] treatment.	70	7.665633e-2	1.000000e+0	1.000000e+0	1.304524e+1	7.665633e-2	1	7.665633e-2	1.000000e+0	63	5.444710e-2	1.000000e+0	1.000000e+0	1.811345e+1	5.520758e-2	1	498	5.000000e-1	2.008032e-3	unnamed	PALLD
MSigDB Perturbation	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	Genes up-regulated in T24 (bladder cancer) cells in response to the photodynamic therapy (PDT) stress.	71	7.787022e-2	1.000000e+0	1.000000e+0	1.284188e+1	7.787022e-2	1	7.787022e-2	1.000000e+0	74	8.555712e-2	1.000000e+0	1.000000e+0	1.143283e+1	8.746744e-2	1	789	5.000000e-1	1.267427e-3	unnamed	PALLD
MSigDB Perturbation	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN	Genes down-regulated in the urogenital sinus (UGS) of day E16 females exposed to the androgen dihydrotestosterone [PubChem=10635] for 48 h.	72	7.798954e-2	1.000000e+0	1.000000e+0	1.282223e+1	7.798954e-2	1	7.798954e-2	1.000000e+0	54	4.558673e-2	1.000000e+0	1.000000e+0	2.168389e+1	4.611718e-2	1	416	5.000000e-1	2.403846e-3	unnamed	PALLD
MSigDB Perturbation	ACEVEDO_LIVER_CANCER_UP	Genes up-regulated in hepatocellular carcinoma (HCC) compared to normal liver samples.	73	7.903216e-2	1.000000e+0	1.000000e+0	1.265308e+1	7.903216e-2	1	7.903216e-2	1.000000e+0	76	1.017052e-1	1.000000e+0	1.000000e+0	9.575902e+0	1.044288e-1	1	942	5.000000e-1	1.061571e-3	unnamed	PALLD
MSigDB Perturbation	NUYTTEN_NIPP1_TARGETS_UP	Genes up-regulated in PC3 cells (prostate cancer) after knockdown of NIPP1 [GeneID=5511] by RNAi.	74	8.459132e-2	1.000000e+0	1.000000e+0	1.182154e+1	8.459132e-2	1	8.459132e-2	1.000000e+0	73	8.014245e-2	1.000000e+0	1.000000e+0	1.222290e+1	8.181365e-2	1	738	5.000000e-1	1.355014e-3	unnamed	CBR4
MSigDB Perturbation	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	Genes down-regulated in poorly differentiated thyroid carcinoma (PDTC) compared to normal thyroid tissue.	75	8.630244e-2	1.000000e+0	1.000000e+0	1.158716e+1	8.630244e-2	1	8.630244e-2	1.000000e+0	72	7.854686e-2	1.000000e+0	1.000000e+0	1.247649e+1	8.015077e-2	1	723	5.000000e-1	1.383126e-3	unnamed	CBR4
MSigDB Perturbation	BRUINS_UVC_RESPONSE_LATE	Late response genes: differentially expressed only 12 h after UV-C irradiation of MEF cells (embryonic fibroblast).	76	1.021113e-1	1.000000e+0	1.000000e+0	9.793235e+0	1.021113e-1	1	1.021113e-1	1.000000e+0	77	1.178136e-1	1.000000e+0	1.000000e+0	8.230383e+0	1.215010e-1	1	1096	5.000000e-1	9.124088e-4	unnamed	CBR4
MSigDB Perturbation	CUI_TCF21_TARGETS_2_DN	All significantly down-regulated genes in kidney glomeruli isolated from TCF21 [Gene ID=6943] knockout mice.	77	1.186115e-1	1.000000e+0	1.000000e+0	8.430888e+0	1.186115e-1	1	1.186115e-1	1.000000e+0	75	8.661694e-2	1.000000e+0	1.000000e+0	1.128974e+1	8.857602e-2	1	799	5.000000e-1	1.251564e-3	unnamed	PALLD
MSigDB Perturbation	BLALOCK_ALZHEIMERS_DISEASE_UP	Genes up-regulated in brain from patients with Alzheimer's disease.	78	1.561268e-1	1.000000e+0	1.000000e+0	6.405052e+0	1.561268e-1	1	1.561268e-1	1.000000e+0	78	1.768717e-1	1.000000e+0	1.000000e+0	5.391811e+0	1.854664e-1	1	1673	5.000000e-1	5.977286e-4	unnamed	PALLD
MSigDB Predicted Promoter Motifs	V$STAT5B_01	Motif NAWTTCYNGGAAWTN matches STAT5B: signal transducer and activator of transcription 5B	1	2.472553e-2	1.000000e+0	1.000000e+0	4.044403e+1	2.472553e-2	1	2.472553e-2	1.000000e+0	1	2.632043e-2	1.000000e+0	1.000000e+0	3.774268e+1	2.649521e-2	1	239	5.000000e-1	4.184100e-3	unnamed	PALLD
MSigDB Predicted Promoter Motifs	V$STAT5A_01	Motif NAWTTCYNGGAANYN matches STAT5A: signal transducer and activator of transcription 5A	2	2.617707e-2	1.000000e+0	1.000000e+0	3.820137e+1	2.617707e-2	1	2.617707e-2	1.000000e+0	2	2.675795e-2	1.000000e+0	1.000000e+0	3.712140e+1	2.693864e-2	1	243	5.000000e-1	4.115226e-3	unnamed	PALLD
MSigDB Predicted Promoter Motifs	TTCYNRGAA_V$STAT5B_01	Motif TTCYNRGAA matches STAT5B: signal transducer and activator of transcription 5B	3	3.281228e-2	1.000000e+0	1.000000e+0	3.047639e+1	3.281228e-2	1	3.281228e-2	1.000000e+0	6	3.516110e-2	1.000000e+0	1.000000e+0	2.818906e+1	3.547475e-2	1	320	5.000000e-1	3.125000e-3	unnamed	PALLD
MSigDB Predicted Promoter Motifs	V$PR_Q2	Motif NWNAGRACAN matches NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)	4	3.657682e-2	1.000000e+0	1.000000e+0	2.733972e+1	3.657682e-2	1	3.657682e-2	1.000000e+0	4	2.752338e-2	1.000000e+0	1.000000e+0	3.608200e+1	2.771465e-2	1	250	5.000000e-1	4.000000e-3	unnamed	PALLD
MSigDB Predicted Promoter Motifs	V$CEBP_Q3	Motif NNNTKNNGNAAN matches CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha	5	4.116827e-2	1.000000e+0	1.000000e+0	2.429055e+1	4.116827e-2	1	4.116827e-2	1.000000e+0	3	2.730472e-2	1.000000e+0	1.000000e+0	3.637298e+1	2.749293e-2	1	248	5.000000e-1	4.032258e-3	unnamed	PALLD
MSigDB Predicted Promoter Motifs	V$CEBP_01	Motif NNTKTGGWNANNN matches CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha	6	4.638036e-2	1.000000e+0	1.000000e+0	2.156085e+1	4.638036e-2	1	4.638036e-2	1.000000e+0	5	2.861633e-2	1.000000e+0	1.000000e+0	3.469423e+1	2.882324e-2	1	260	5.000000e-1	3.846154e-3	unnamed	PALLD
MSigDB Predicted Promoter Motifs	CTAWWWATA_V$RSRFC4_Q2	Motif CTAWWWATA matches MEF2A: MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A)	7	5.048395e-2	1.000000e+0	1.000000e+0	1.980828e+1	5.048395e-2	1	5.048395e-2	1.000000e+0	7	4.048959e-2	1.000000e+0	1.000000e+0	2.444580e+1	4.090682e-2	1	369	5.000000e-1	2.710027e-3	unnamed	PALLD
MSigDB Predicted Promoter Motifs	YTATTTTNR_V$MEF2_02	Motif YTATTTTNR matches MEF2A: MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A)	8	1.016792e-1	1.000000e+0	1.000000e+0	9.834855e+0	1.016792e-1	1	1.016792e-1	1.000000e+0	8	7.268454e-2	1.000000e+0	1.000000e+0	1.350374e+1	7.405354e-2	1	668	5.000000e-1	1.497006e-3	unnamed	PALLD
MSigDB Predicted Promoter Motifs	CAGGTG_V$E12_Q6	Motif CAGGTG matches TCF3: transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	9	2.657598e-1	1.000000e+0	1.000000e+0	3.762796e+0	2.657598e-1	1	2.657598e-1	1.000000e+0	10	2.455801e-1	1.000000e+0	1.000000e+0	3.804513e+0	2.628457e-1	1	2371	5.000000e-1	4.217630e-4	unnamed	PALLD
MSigDB Predicted Promoter Motifs	TTGTTT_V$FOXO4_01	Motif TTGTTT matches MLLT7: myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 7	10	2.767434e-1	1.000000e+0	1.000000e+0	3.613455e+0	2.767434e-1	1	2.767434e-1	1.000000e+0	9	2.050899e-1	1.000000e+0	1.000000e+0	4.611708e+0	2.168394e-1	1	1956	5.000000e-1	5.112474e-4	unnamed	PALLD
MSigDB miRNA Motifs	CAGCTTT,MIR-320	Targets of MicroRNA CAGCTTT,MIR-320	1	3.834921e-2	1.000000e+0	1.000000e+0	2.607616e+1	3.834921e-2	1	3.834921e-2	1.000000e+0	1	2.763270e-2	1.000000e+0	1.000000e+0	3.593825e+1	2.782551e-2	1	251	5.000000e-1	3.984064e-3	unnamed	PALLD
MSigDB miRNA Motifs	TTGCCAA,MIR-182	Targets of MicroRNA TTGCCAA,MIR-182	2	5.193079e-2	1.000000e+0	1.000000e+0	1.925640e+1	5.193079e-2	1	5.193079e-2	1.000000e+0	2	3.483439e-2	1.000000e+0	1.000000e+0	2.845584e+1	3.514218e-2	1	317	5.000000e-1	3.154574e-3	unnamed	PALLD
MSigDB miRNA Motifs	AATGTGA,MIR-23A,MIR-23B	Targets of MicroRNA AATGTGA,MIR-23A,MIR-23B	3	6.786184e-2	1.000000e+0	1.000000e+0	1.473582e+1	6.786184e-2	1	6.786184e-2	1.000000e+0	3	4.417824e-2	1.000000e+0	1.000000e+0	2.238337e+1	4.467602e-2	1	403	5.000000e-1	2.481390e-3	unnamed	PALLD
MSigDB miRNA Motifs	TGAATGT,MIR-181A,MIR-181B,MIR-181C,MIR-181D	Targets of MicroRNA TGAATGT,MIR-181A,MIR-181B,MIR-181C,MIR-181D	4	7.238721e-2	1.000000e+0	1.000000e+0	1.381459e+1	7.238721e-2	1	7.238721e-2	1.000000e+0	4	5.131828e-2	1.000000e+0	1.000000e+0	1.923348e+1	5.199268e-2	1	469	5.000000e-1	2.132196e-3	unnamed	PALLD
MSigDB miRNA Motifs	TGCCTTA,MIR-124A	Targets of MicroRNA TGCCTTA,MIR-124A	5	7.778816e-2	1.000000e+0	1.000000e+0	1.285543e+1	7.778816e-2	1	7.778816e-2	1.000000e+0	5	5.800120e-2	1.000000e+0	1.000000e+0	1.698776e+1	5.886592e-2	1	531	5.000000e-1	1.883239e-3	unnamed	PALLD
MSigDB miRNA Motifs	GTGCCTT,MIR-506	Targets of MicroRNA GTGCCTT,MIR-506	6	8.853209e-2	1.000000e+0	1.000000e+0	1.129534e+1	8.853209e-2	1	8.853209e-2	1.000000e+0	6	7.588448e-2	1.000000e+0	1.000000e+0	1.292335e+1	7.737930e-2	1	698	5.000000e-1	1.432665e-3	unnamed	PALLD
InterPro	IPR020904	Short-chain dehydrogenase/reductase, conserved site	1	2.476677e-3	1.000000e+0	1.000000e+0	4.037667e+2	2.476677e-3	1	2.476677e-3	1.000000e+0	1	3.987038e-3	1.000000e+0	1.000000e+0	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	CBR4
InterPro	IPR002198	Short-chain dehydrogenase/reductase SDR	2	3.988259e-3	1.000000e+0	1.000000e+0	2.507359e+2	3.988259e-3	1	3.988259e-3	1.000000e+0	2	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	CBR4
InterPro	IPR002347	Glucose/ribitol dehydrogenase	3	4.008192e-3	1.000000e+0	1.000000e+0	2.494890e+2	4.008192e-3	1	4.008192e-3	1.000000e+0	3	6.198618e-3	1.000000e+0	1.000000e+0	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	CBR4
InterPro	IPR016040	NAD(P)-binding domain	4	1.496527e-2	1.000000e+0	1.000000e+0	6.682140e+1	1.496527e-2	1	1.496527e-2	1.000000e+0	5	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	CBR4
InterPro	IPR013098	Immunoglobulin I-set	5	3.422246e-2	1.000000e+0	1.000000e+0	2.922057e+1	3.422246e-2	1	3.422246e-2	1.000000e+0	4	1.754933e-2	1.000000e+0	1.000000e+0	5.673270e+1	1.762652e-2	1	159	5.000000e-1	6.289308e-3	unnamed	PALLD
InterPro	IPR003598	Immunoglobulin subtype 2	6	3.509218e-2	1.000000e+0	1.000000e+0	2.849638e+1	3.509218e-2	1	3.509218e-2	1.000000e+0	6	2.314545e-2	1.000000e+0	1.000000e+0	4.295476e+1	2.328031e-2	1	210	5.000000e-1	4.761905e-3	unnamed	PALLD
InterPro	IPR007110	Immunoglobulin-like domain	7	5.020399e-2	1.000000e+0	1.000000e+0	1.991873e+1	5.020399e-2	1	5.020399e-2	1.000000e+0	7	4.710240e-2	1.000000e+0	1.000000e+0	2.097791e+1	4.766920e-2	1	430	5.000000e-1	2.325581e-3	unnamed	PALLD
InterPro	IPR013783	Immunoglobulin-like fold	8	7.916806e-2	1.000000e+0	1.000000e+0	1.263136e+1	7.916806e-2	1	7.916806e-2	1.000000e+0	8	7.161666e-2	1.000000e+0	1.000000e+0	1.370897e+1	7.294496e-2	1	658	5.000000e-1	1.519757e-3	unnamed	PALLD
TreeFam	TF343193	MYPN, PALLD	1	2.357636e-4	1.000000e+0	1.000000e+0	4.241537e+3	2.357636e-4	1	2.357636e-4	1.000000e+0	2	2.217111e-4	1.000000e+0	9.008122e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	PALLD
TreeFam	TF354265	CBR4	2	2.698035e-4	1.000000e+0	1.000000e+0	3.706401e+3	2.698035e-4	1	2.698035e-4	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	CBR4
HGNC Gene Families	SDRC1	SDRC1	1	1.061077e-3	5.071948e-1	5.071948e-1	9.424389e+2	1.061077e-3	1	1.061077e-3	1.000000e+0	1	2.105263e-3	1.000000e+0	1.000000e+0	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	CBR4
HGNC Gene Families	ISET	ISET	2	1.255454e-2	1.000000e+0	1.000000e+0	7.965247e+1	1.255454e-2	1	1.255454e-2	1.000000e+0	2	5.314281e-3	1.000000e+0	1.000000e+0	1.879271e+2	5.321213e-3	1	48	5.000000e-1	2.083333e-2	unnamed	PALLD
Ensembl Genes	14958	PALLD	1	1.830504e-4	1.000000e+0	1.000000e+0	5.462977e+3	1.830504e-4	1	1.830504e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	PALLD
Ensembl Genes	14959	CBR4	2	2.698035e-4	1.000000e+0	1.000000e+0	3.706401e+3	2.698035e-4	1	2.698035e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	CBR4
MSigDB Oncogenic Signatures	RB_P107_DN.V1_DN	Genes down-regulated in primary keratinocytes from RB1 and RBL1 [Gene ID=5925, 5933] skin specific knockout mice.	1	1.058194e-2	1.000000e+0	1.000000e+0	9.450062e+1	1.058194e-2	1	1.058194e-2	1.000000e+0	1	1.402987e-2	1.000000e+0	1.000000e+0	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	CBR4
MSigDB Oncogenic Signatures	KRAS.DF.V1_UP	Genes up-regulated in epithelial lung cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.	2	2.141496e-2	1.000000e+0	1.000000e+0	4.669632e+1	2.141496e-2	1	2.141496e-2	1.000000e+0	3	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	CBR4
MSigDB Oncogenic Signatures	ERB2_UP.V1_DN	Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] and engineered to express ligand-activatable ERBB2 [Gene ID=2064].	3	2.349699e-2	1.000000e+0	1.000000e+0	4.255865e+1	2.349699e-2	1	2.349699e-2	1.000000e+0	4	2.117217e-2	1.000000e+0	9.897989e-1	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	CBR4
MSigDB Oncogenic Signatures	MEK_UP.V1_DN	Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active MAP2K1 [Gene ID=5604] gene.	4	2.405783e-2	1.000000e+0	1.000000e+0	4.156651e+1	2.405783e-2	1	2.405783e-2	1.000000e+0	8	2.424086e-2	1.000000e+0	5.666301e-1	4.100227e+1	2.438889e-2	1	220	5.000000e-1	4.545455e-3	unnamed	CBR4
MSigDB Oncogenic Signatures	PRC2_EDD_UP.V1_DN	Genes down-regulated in TIG3 cells (fibroblasts) upon knockdown of EED [Gene ID=8726] gene.	5	2.471277e-2	1.000000e+0	9.242576e-1	4.046491e+1	2.471277e-2	1	2.471277e-2	1.000000e+0	2	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	CBR4
MSigDB Oncogenic Signatures	EGFR_UP.V1_DN	Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] and engineered to express ligand-activatable EGFR [Gene ID=1956].	6	2.521915e-2	1.000000e+0	7.859968e-1	3.965241e+1	2.521915e-2	1	2.521915e-2	1.000000e+0	7	2.413134e-2	1.000000e+0	6.446515e-1	4.118950e+1	2.427803e-2	1	219	5.000000e-1	4.566210e-3	unnamed	CBR4
MSigDB Oncogenic Signatures	CAMP_UP.V1_DN	Genes down-regulated in primary thyrocyte cultures in response to cAMP signaling pathway activation by thyrotropin (TSH).	7	2.584038e-2	1.000000e+0	6.903073e-1	3.869912e+1	2.584038e-2	1	2.584038e-2	1.000000e+0	5	2.193980e-2	1.000000e+0	8.205485e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	PALLD
MSigDB Oncogenic Signatures	STK33_SKM_UP	Genes up-regulated in SKM-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.	8	3.004525e-2	1.000000e+0	7.023077e-1	3.328314e+1	3.004525e-2	1	3.004525e-2	1.000000e+0	9	3.069123e-2	1.000000e+0	6.376956e-1	3.233154e+1	3.092955e-2	1	279	5.000000e-1	3.584229e-3	unnamed	PALLD
MSigDB Oncogenic Signatures	RAF_UP.V1_DN	Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active RAF1 [Gene ID=5894] gene.	9	3.391411e-2	1.000000e+0	7.046598e-1	2.948625e+1	3.391411e-2	1	3.391411e-2	1.000000e+0	5	2.193980e-2	1.000000e+0	8.205485e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	PALLD
MSigDB Oncogenic Signatures	NFE2L2.V2	Genes up-regulated in MEF cells (embryonic fibroblasts) with knockout of NFE2L2 [Gene ID=4780] gene.	10	4.485003e-2	1.000000e+0	8.386956e-1	2.229653e+1	4.485003e-2	1	4.485003e-2	1.000000e+0	10	4.645297e-2	1.000000e+0	8.686705e-1	2.127476e+1	4.700405e-2	1	424	5.000000e-1	2.358491e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 24 h.	1	1.018445e-2	1.000000e+0	1.000000e+0	9.818892e+1	1.018445e-2	1	1.018445e-2	1.000000e+0	20	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	CBR4
MSigDB Immunologic Signatures	GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP	Genes up-regulated in comparison of IgD+ peripheral blood B cells versus IgD- naive tonsil B cells.	2	1.201537e-2	1.000000e+0	1.000000e+0	8.322673e+1	1.201537e-2	1	1.201537e-2	1.000000e+0	54	2.193980e-2	1.000000e+0	7.760189e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	CBR4
MSigDB Immunologic Signatures	GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 48 h.	3	1.433084e-2	1.000000e+0	1.000000e+0	6.977957e+1	1.433084e-2	1	1.433084e-2	1.000000e+0	5	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	CBR4
MSigDB Immunologic Signatures	GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 3 h versus PBMC cultured for 3 h with YF17D vaccine.	4	1.440917e-2	1.000000e+0	1.000000e+0	6.940026e+1	1.440917e-2	1	1.440917e-2	1.000000e+0	44	2.172051e-2	1.000000e+0	9.428676e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	CBR4
MSigDB Immunologic Signatures	GSE3982_EOSINOPHIL_VS_TH2_DN	Genes down-regulated in comparison of eosinophils versus Th2 cells.	5	1.466270e-2	1.000000e+0	1.000000e+0	6.820027e+1	1.466270e-2	1	1.466270e-2	1.000000e+0	9	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN	Genes down-regulated in comparison of eosinophils treated with IL25 [GeneID=64806] versus neutrophils treated with IL25 [GeneID=64806].	6	1.490249e-2	1.000000e+0	1.000000e+0	6.710289e+1	1.490249e-2	1	1.490249e-2	1.000000e+0	20	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_CPG_2H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 2 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 2 h.	7	1.542839e-2	1.000000e+0	1.000000e+0	6.481557e+1	1.542839e-2	1	1.542839e-2	1.000000e+0	16	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	CBR4
MSigDB Immunologic Signatures	GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN	Genes down-regulated in comparison of type 2 myeloid (T2M) cells treated with IL25 [GeneID=64806] versus neutrophils treated with IL25 [GeneID=64806].	8	1.553964e-2	1.000000e+0	1.000000e+0	6.435154e+1	1.553964e-2	1	1.553964e-2	1.000000e+0	16	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE13306_TREG_RA_VS_TCONV_RA_DN	Genes down-regulated in regulatory T cell (Treg) treated with retinoic acid (tretinoin) [PubChem=444795] versus conventional T cells.	9	1.564968e-2	1.000000e+0	1.000000e+0	6.389909e+1	1.564968e-2	1	1.564968e-2	1.000000e+0	9	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN	Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus CD4 [GeneID=920] Int CD8 thymocytes.	10	1.568037e-2	1.000000e+0	1.000000e+0	6.377401e+1	1.568037e-2	1	1.568037e-2	1.000000e+0	27	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	CBR4
MSigDB Immunologic Signatures	GSE27786_LIN_NEG_VS_NEUTROPHIL_UP	Genes up-regulated in comparison of lineage negative versus neutrophils.	11	1.598313e-2	1.000000e+0	1.000000e+0	6.256598e+1	1.598313e-2	1	1.598313e-2	1.000000e+0	14	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	CBR4
MSigDB Immunologic Signatures	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 24 h versus the untreated cells at 24 h.	12	1.600241e-2	1.000000e+0	1.000000e+0	6.249059e+1	1.600241e-2	1	1.600241e-2	1.000000e+0	1	1.831837e-2	1.000000e+0	1.000000e+0	5.434036e+1	1.840253e-2	1	166	5.000000e-1	6.024096e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE3982_EOSINOPHIL_VS_NKCELL_DN	Genes down-regulated in comparison of eosinophils versus NK cells.	13	1.624230e-2	1.000000e+0	1.000000e+0	6.156764e+1	1.624230e-2	1	1.624230e-2	1.000000e+0	9	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN	Genes down-regulated in comparison of central memory CD4 [GeneID=920] T cells versus Th2 cells.	14	1.629662e-2	1.000000e+0	1.000000e+0	6.136242e+1	1.629662e-2	1	1.629662e-2	1.000000e+0	44	2.172051e-2	1.000000e+0	9.428676e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE360_DC_VS_MAC_L_DONOVANI_UP	Genes up-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus macrophages exposed to L. donovani.	15	1.715068e-2	1.000000e+0	1.000000e+0	5.830672e+1	1.715068e-2	1	1.715068e-2	1.000000e+0	58	2.325502e-2	1.000000e+0	7.658119e-1	4.275118e+1	2.339116e-2	1	211	5.000000e-1	4.739336e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP	Genes up-regulated in comparison of dendritic cells (DC) exposed to M. tuberculosis versus macrophages exposed to L. major.	16	1.738783e-2	1.000000e+0	1.000000e+0	5.751150e+1	1.738783e-2	1	1.738783e-2	1.000000e+0	20	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) exposed to 50 worms/well B. malayi versus DC exposed to M. tuberculosis	17	1.743973e-2	1.000000e+0	1.000000e+0	5.734033e+1	1.743973e-2	1	1.743973e-2	1.000000e+0	32	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	CBR4
MSigDB Immunologic Signatures	GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	Genes up-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] versus macrophages cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cyc.	18	1.764016e-2	1.000000e+0	1.000000e+0	5.668882e+1	1.764016e-2	1	1.764016e-2	1.000000e+0	32	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	CBR4
MSigDB Immunologic Signatures	GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN	Genes down-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10 versus CD25- T cells treated with IL4 [GeneID=3565] at 10 h.	19	1.764296e-2	1.000000e+0	1.000000e+0	5.667984e+1	1.764296e-2	1	1.764296e-2	1.000000e+0	44	2.172051e-2	1.000000e+0	9.428676e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_DN	Genes down-regulated in comparison of CTRLrv versus FOXP3rv (see Fig. 1 for details).	20	1.783889e-2	1.000000e+0	1.000000e+0	5.605731e+1	1.783889e-2	1	1.783889e-2	1.000000e+0	5	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE3982_DC_VS_NEUTROPHIL_UP	Genes up-regulated in comparison of dendritic cells (DC) versus neutrophils.	21	1.830333e-2	1.000000e+0	1.000000e+0	5.463487e+1	1.830333e-2	1	1.830333e-2	1.000000e+0	20	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	Genes down-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cys (TLR2 agonist).	22	1.842864e-2	1.000000e+0	1.000000e+0	5.426335e+1	1.842864e-2	1	1.842864e-2	1.000000e+0	8	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	CBR4
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_PAM3CSK4_12H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 12 h versus those stimulated with Pam3Csk4 (TLR1/2 agonist) at 12 h.	23	1.857861e-2	1.000000e+0	1.000000e+0	5.382533e+1	1.857861e-2	1	1.857861e-2	1.000000e+0	27	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE3982_EOSINOPHIL_VS_DC_DN	Genes down-regulated in comparison of eosinophils versus dendritic cells (DC).	24	1.858188e-2	1.000000e+0	1.000000e+0	5.381588e+1	1.858188e-2	1	1.858188e-2	1.000000e+0	56	2.226868e-2	1.000000e+0	7.595210e-1	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP	Genes up-regulated in comparison of naive B cells versus Ig isotype switched memory B cells.	25	1.871702e-2	1.000000e+0	1.000000e+0	5.342731e+1	1.871702e-2	1	1.871702e-2	1.000000e+0	7	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_24H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 24 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 24 h.	26	1.874120e-2	1.000000e+0	1.000000e+0	5.335839e+1	1.874120e-2	1	1.874120e-2	1.000000e+0	54	2.193980e-2	1.000000e+0	7.760189e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_CPG_12H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 12 h versus those stimulated with CpG DNA (TLR9 agonist) at 12 h.	27	1.874212e-2	1.000000e+0	1.000000e+0	5.335576e+1	1.874212e-2	1	1.874212e-2	1.000000e+0	37	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 12 h versus the untreated cells at 12 h.	28	1.880484e-2	1.000000e+0	1.000000e+0	5.317780e+1	1.880484e-2	1	1.880484e-2	1.000000e+0	2	1.864787e-2	1.000000e+0	1.000000e+0	5.337574e+1	1.873510e-2	1	169	5.000000e-1	5.917160e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_8H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 8 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 8 h.	29	1.904330e-2	1.000000e+0	1.000000e+0	5.251191e+1	1.904330e-2	1	1.904330e-2	1.000000e+0	51	2.183015e-2	1.000000e+0	8.175605e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	CBR4
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_4H_LPS_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 0.5 h versus those stimulated at 4 h.	30	1.906052e-2	1.000000e+0	1.000000e+0	5.246447e+1	1.906052e-2	1	1.906052e-2	1.000000e+0	20	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_LPS_8H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 8 h versus those stimulated with LPS (TLR4 agonist) at 8 h.	31	1.913192e-2	1.000000e+0	1.000000e+0	5.226867e+1	1.913192e-2	1	1.913192e-2	1.000000e+0	27	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE3982_BCELL_VS_TH2_DN	Genes down-regulated in comparison of B cells versus Th2 cells.	32	1.923272e-2	1.000000e+0	1.000000e+0	5.199473e+1	1.923272e-2	1	1.923272e-2	1.000000e+0	32	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_12H_CPG_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 0.5 h versus those stimulated with CpG DNA (TLR9 agonist) at 12 h.	33	1.940816e-2	1.000000e+0	1.000000e+0	5.152472e+1	1.940816e-2	1	1.940816e-2	1.000000e+0	44	2.172051e-2	1.000000e+0	9.428676e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP	Genes up-regulated in comparison of polysome bound (translated) mRNA versus total mRNA in dendritic cells.	34	1.954301e-2	1.000000e+0	1.000000e+0	5.116918e+1	1.954301e-2	1	1.954301e-2	1.000000e+0	37	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	CBR4
MSigDB Immunologic Signatures	GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP	Genes up-regulated in comparison of dendritic cells (DC) exposed to 50 worm/well B. malayi versus macrophages exposed to 50 worms/well B. malayi.	35	1.987899e-2	1.000000e+0	1.000000e+0	5.030435e+1	1.987899e-2	1	1.987899e-2	1.000000e+0	51	2.183015e-2	1.000000e+0	8.175605e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_POLYIC_4H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 4 h versus those stimulated with poly(I:C) (TLR3 agonist) at 4 h.	36	1.992883e-2	1.000000e+0	1.000000e+0	5.017856e+1	1.992883e-2	1	1.992883e-2	1.000000e+0	37	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN	Genes down-regulated in comparison of central memory CD4 [GeneID=920] T cells versus NK cells.	37	2.011158e-2	1.000000e+0	1.000000e+0	4.972259e+1	2.011158e-2	1	2.011158e-2	1.000000e+0	32	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_PAM3CSK4_1H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 1 h versus those stimulated with Pam3Csk4 (TLR1/2 agonist) at 1 h.	38	2.017131e-2	1.000000e+0	1.000000e+0	4.957535e+1	2.017131e-2	1	2.017131e-2	1.000000e+0	16	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_POLYIC_12H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 12 h versus those stimulated with poly(I:C) (TLR3 agonist) at 12 h.	39	2.035731e-2	1.000000e+0	9.969862e-1	4.912240e+1	2.035731e-2	1	2.035731e-2	1.000000e+0	27	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_POLYIC_8H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 8 h versus those stimulated with poly(I:C) (TLR3 agonist) at 8 h.	40	2.039623e-2	1.000000e+0	9.739200e-1	4.902868e+1	2.039623e-2	1	2.039623e-2	1.000000e+0	44	2.172051e-2	1.000000e+0	9.428676e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 12 h versus PBMC cultured for 12 h with YF17D vaccine.	41	2.043617e-2	1.000000e+0	9.520265e-1	4.893285e+1	2.043617e-2	1	2.043617e-2	1.000000e+0	37	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_PAM3CSK4_8H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 8 h versus those stimulated with Pam3Csk4 (TLR1/2 agonist) at 8 h.	42	2.061006e-2	1.000000e+0	9.372670e-1	4.852000e+1	2.061006e-2	1	2.061006e-2	1.000000e+0	44	2.172051e-2	1.000000e+0	9.428676e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE3982_DC_VS_BCELL_UP	Genes up-regulated in comparison of dendritic cells (DC) versus B cells.	43	2.075094e-2	1.000000e+0	9.217278e-1	4.819060e+1	2.075094e-2	1	2.075094e-2	1.000000e+0	59	2.336458e-2	1.000000e+0	7.563788e-1	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE3982_EOSINOPHIL_VS_BASOPHIL_DN	Genes down-regulated in comparison of eosinophils versus basophils.	44	2.076503e-2	1.000000e+0	9.013911e-1	4.815788e+1	2.076503e-2	1	2.076503e-2	1.000000e+0	9	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP	Genes up-regulated in comparison of directly activated CD4 [GeneID=920] T cells versus bystander activated CD4 [GeneID=920] T cells.	45	2.098226e-2	1.000000e+0	8.905804e-1	4.765931e+1	2.098226e-2	1	2.098226e-2	1.000000e+0	16	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP	Genes up-regulated in comparison of contols neutrophils versus those infected with a bacterium (F. nucleatum).	46	2.109403e-2	1.000000e+0	8.758608e-1	4.740678e+1	2.109403e-2	1	2.109403e-2	1.000000e+0	4	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_LPS_6H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 6 h versus those stimulated with LPS (TLR4 agonist) at 6 h.	47	2.124962e-2	1.000000e+0	8.635484e-1	4.705967e+1	2.124962e-2	1	2.124962e-2	1.000000e+0	37	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_LPS_2H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 2 h versus those stimulated with LPS (TLR4 agonist) at 2 h.	48	2.143171e-2	1.000000e+0	8.528035e-1	4.665984e+1	2.143171e-2	1	2.143171e-2	1.000000e+0	14	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_CPG_4H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 4 h versus those stimulated with CpG DNA (TLR9 agonist) at 4 h.	49	2.146572e-2	1.000000e+0	8.367250e-1	4.658591e+1	2.146572e-2	1	2.146572e-2	1.000000e+0	26	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_PAM3CSK4_6H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 6 h versus those stimulated with Pam3Csk4 (TLR1/2 agonist) at 6 h.	50	2.187083e-2	1.000000e+0	8.354657e-1	4.572300e+1	2.187083e-2	1	2.187083e-2	1.000000e+0	32	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP	Genes up-regulated in comparison of control microglia cells versus those 24 h after stimulation with IFNG [GeneID=3458].	51	2.262978e-2	1.000000e+0	8.475074e-1	4.418957e+1	2.262978e-2	1	2.262978e-2	1.000000e+0	37	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP	Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th1 cells.	52	2.272423e-2	1.000000e+0	8.346784e-1	4.400589e+1	2.272423e-2	1	2.272423e-2	1.000000e+0	20	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	CBR4
MSigDB Immunologic Signatures	GSE17721_LPS_VS_POLYIC_2H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 2 h versus DC cells stimulated with poly(I:C) (TLR3 agonist) at 2 h.	53	2.288378e-2	1.000000e+0	8.246796e-1	4.369906e+1	2.288378e-2	1	2.288378e-2	1.000000e+0	27	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE360_DC_VS_MAC_T_GONDII_UP	Genes up-regulated in comparison of dendritic cells (DC) exposed to T. gondii versus macrophages exposed to T. gondii.	54	2.297377e-2	1.000000e+0	8.125908e-1	4.352790e+1	2.297377e-2	1	2.297377e-2	1.000000e+0	51	2.183015e-2	1.000000e+0	8.175605e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE3982_BCELL_VS_BASOPHIL_DN	Genes down-regulated in comparison of B cells versus basophils.	55	2.307656e-2	1.000000e+0	8.013860e-1	4.333402e+1	2.307656e-2	1	2.307656e-2	1.000000e+0	56	2.226868e-2	1.000000e+0	7.595210e-1	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE3982_BCELL_VS_NKCELL_DN	Genes down-regulated in comparison of B cells versus NK cells.	56	2.313552e-2	1.000000e+0	7.890865e-1	4.322358e+1	2.313552e-2	1	2.313552e-2	1.000000e+0	9	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_POLYIC_6H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 6 h versus those stimulated with poly(I:C) (TLR3 agonist) at 6 h.	57	2.440819e-2	1.000000e+0	8.178885e-1	4.096986e+1	2.440819e-2	1	2.440819e-2	1.000000e+0	37	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	PALLD
MSigDB Immunologic Signatures	GSE20366_TREG_VS_TCONV_UP	Genes up-regulated in comparison of TregCD103-Klrg1 versus TconvLP (see Table 1S in the paper for details).	58	2.481726e-2	1.000000e+0	8.172580e-1	4.029454e+1	2.481726e-2	1	2.481726e-2	1.000000e+0	44	2.172051e-2	1.000000e+0	9.428676e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	CBR4
MSigDB Immunologic Signatures	GSE13411_NAIVE_VS_MEMORY_BCELL_UP	Genes up-regulated in comparison of naive B cells versus memory B cells.	59	2.543573e-2	1.000000e+0	8.234279e-1	3.931478e+1	2.543573e-2	1	2.543573e-2	1.000000e+0	3	1.941648e-2	1.000000e+0	1.000000e+0	5.125284e+1	1.951111e-2	1	176	5.000000e-1	5.681818e-3	unnamed	PALLD
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
